,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af
0,1,M,,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,,,,,,,,,,
1,2,A,P,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985896-60985896, hg38,18:63318663-63318663","hg19,18:g.60985896C>G, hg38,18:g.63318663C>G",0.152,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, mediastinum","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, primary_central_nervous_system_B_cell_lymphoma, lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",,
2,2,A,S,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC",dlbcl_dfci_2018,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985896-60985896, hg38,18:63318663-63318663","hg19,18:g.60985896C>A, hg38,18:g.63318663C>A",0.134,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
3,2,A,T,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, glioma_mskcc_2019, lymphoma_cellline_msk_2020, mbn_mdacc_2013, nhl_bcgsc_2011, nhl_bcgsc_2013","Diffuse Glioma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985896-60985896, hg38,18:63318663-63318663","hg19,18:g.60985896C>T, hg38,18:g.63318663C>T",0.146,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, primary_central_nervous_system_B_cell_lymphoma",,
4,2,A,V,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC","coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,18:60985895-60985895, hg38,18:63318662-63318662","hg19,18:g.60985895G>A, hg38,18:g.63318662G>A",0.123,"large_intestine, colon, ascending, stomach","carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma",0.0000080872124996,
5,3,H,D,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC","dlbc_tcga_pan_can_atlas_2018, mbn_mdacc_2013, nhl_bcgsc_2011","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Non-Hodgkin Lymphoma","hg19,18:60985893-60985893, hg38,18:63318660-63318660","hg19,18:g.60985893G>C, hg38,18:g.63318660G>C",0.067,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
6,3,H,L,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985892-60985892, hg38,18:63318659-63318659","hg19,18:g.60985892T>A, hg38,18:g.63318659T>A",0.066,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
7,3,H,N,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985893-60985893, hg38,18:63318660-63318660","hg19,18:g.60985893G>T, hg38,18:g.63318660G>T",0.043,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
8,3,H,P,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,cBioPortal,"dlbc_broad_2012, dlbcl_dfci_2018","Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985892-60985892","hg19,18:g.60985892T>G",0.138,,,,
9,3,H,Q,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985891-60985891, hg38,18:63318658-63318658","hg19,18:g.60985891G>C, hg38,18:g.63318658G>T",0.051,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
10,4,A,G,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017, pcnsl_mayo_2015","Mature B-Cell Neoplasms, Mixed Cancer Types, Primary DLBCL of the central nervous system","hg19,18:60985889-60985889, hg38,18:63318656-63318656","hg19,18:g.60985889G>C, hg38,18:g.63318656G>C",0.058,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
11,4,A,P,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016, pancan_pcawg_2020","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,18:60985890-60985890, hg38,18:63318657-63318657","hg19,18:g.60985890C>G, hg38,18:g.63318657C>G",0.029,"haematopoietic_and_lymphoid_tissue, lung","carcinoma, adenocarcinoma, lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
12,4,A,S,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,COSMIC,,,"hg38,18:63318657-63318657","hg38,18:g.63318657C>A",0.035,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000080759788086,
13,4,A,T,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985890-60985890, hg38,18:63318657-63318657","hg19,18:g.60985890C>T, hg38,18:g.63318657C>T",0.043,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, soft_tissue","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
14,4,A,V,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, mbn_mdacc_2013, msk_impact_2017, pancan_pcawg_2020","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985889-60985889, hg38,18:63318656-63318656","hg19,18:g.60985889G>A, hg38,18:g.63318656G>A",0.070,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
15,5,G,A,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM|FHA phosphopeptide ligands, 5-11, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985886-60985886","hg19,18:g.60985886C>G",0.146,,,,
16,5,G,E,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM|FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, dlbcl_duke_2017, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985886-60985886, hg38,18:63318653-63318653","hg19,18:g.60985886C>T, hg38,18:g.63318653C>T",0.146,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
17,5,G,R,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM|FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,18:60985887-60985887, hg38,18:63318654-63318654","hg19,18:g.60985887C>G, hg38,18:g.63318654C>T",0.103,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
18,5,G,V,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM|FHA phosphopeptide ligands, 5-11, ELM",,COSMIC,,,"hg38,18:63318653-63318653","hg38,18:g.63318653C>A",0.163,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
19,5,G,W,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM|FHA phosphopeptide ligands, 5-11, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,18:60985887-60985887","hg19,18:g.60985887C>A",0.189,,,,
20,6,R,G,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC","dlbcl_dfci_2018, mbn_mdacc_2013, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985884-60985884, hg38,18:63318651-63318651","hg19,18:g.60985884T>C, hg38,18:g.63318651T>C",0.025,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
21,6,R,I,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,COSMIC,,,"hg38,18:63318650-63318650","hg38,18:g.63318650C>A",0.139,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
22,6,R,K,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985883-60985883, hg38,18:63318650-63318650","hg19,18:g.60985883C>T, hg38,18:g.63318650C>T",0.022,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
23,6,R,S,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,COSMIC,,,"hg38,18:63318649-63318649","hg38,18:g.63318649T>G",0.049,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
24,6,R,T,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985883-60985883, hg38,18:63318650-63318650","hg19,18:g.60985883C>G, hg38,18:g.63318650C>G",0.027,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, soft_tissue","lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, atypical, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
25,7,T,A,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985881-60985881, hg38,18:63318648-63318648","hg19,18:g.60985881T>C, hg38,18:g.63318648T>C",0.027,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
26,7,T,I,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985880-60985880, hg38,18:63318647-63318647","hg19,18:g.60985880G>A, hg38,18:g.63318647G>A",0.047,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, abdomen, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, small_intestine","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
27,7,T,K,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,COSMIC,,,"hg38,18:63318647-63318647","hg38,18:g.63318647G>T",0.036,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
28,7,T,P,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985881-60985881, hg38,18:63318648-63318648","hg19,18:g.60985881T>G, hg38,18:g.63318648T>G",0.096,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, retroperitoneum","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
29,7,T,R,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, lymphoma_cellline_msk_2020, nhl_bcgsc_2013","Lymphoid, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985880-60985880, hg38,18:63318647-63318647","hg19,18:g.60985880G>C, hg38,18:g.63318647G>C",0.041,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
30,7,T,S,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,cBioPortal,"dlbcl_dfci_2018, msk_access_2021","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985881-60985881","hg19,18:g.60985881T>A",0.049,,,,
31,8,G,A,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,COSMIC,,,"hg38,18:63318644-63318644","hg38,18:g.63318644C>G",0.117,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
32,8,G,E,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, dlbcl_dfci_2018, dlbcl_duke_2017, mbn_mdacc_2013, msk_impact_2017, pancan_pcawg_2020","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985876-60985877, hg19,18:60985877-60985877, hg38,18:63318643-63318644, hg38,18:63318644-63318644","hg19,18:g.60985876_60985877delinsTT, hg19,18:g.60985877C>T, hg38,18:g.63318643_63318644delinsTT, hg38,18:g.63318644C>T",0.161,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, skin","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",0.0000080625655083,
33,8,G,R,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985878-60985878, hg38,18:63318645-63318645","hg19,18:g.60985878C>G, hg19,18:g.60985878C>T, hg38,18:g.63318645C>T","0.134, 0.138",haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
34,8,G,W,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM",,COSMIC,,,"hg38,18:63318645-63318645","hg38,18:g.63318645C>A",0.180,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
35,9,Y,C,P,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM|Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985874-60985874, hg38,18:63318641-63318641","hg19,18:g.60985874T>C, hg38,18:g.63318641T>C",0.238,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
36,9,Y,F,P,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM|Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,COSMIC,,,"hg38,18:63318641-63318641","hg38,18:g.63318641T>A",0.167,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, follicular_lymphoma",,
37,9,Y,H,P,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM|Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, mbn_mdacc_2013, msk_met_2021","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985875-60985875, hg38,18:63318642-63318642","hg19,18:g.60985875A>G, hg38,18:g.63318642A>G",0.275,large_intestine,"carcinoma, adenocarcinoma",,
38,9,Y,S,P,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM|Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,COSMIC,,,"hg38,18:63318641-63318641","hg38,18:g.63318641T>G",0.208,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
39,10,D,E,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM|Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,cBioPortal,"dlbcl_duke_2017, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985870-60985870","hg19,18:g.60985870A>C, hg19,18:g.60985870A>T",0.140,,,,
40,10,D,N,,,,,,,,,,C,"FHA phosphopeptide ligands, 5-11, ELM|Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018",Cutaneous Melanoma,"hg19,18:60985872-60985872, hg38,18:63318639-63318639","hg19,18:g.60985872C>T, hg38,18:g.63318639C>T",0.120,"haematopoietic_and_lymphoid_tissue, skin","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, malignant_melanoma",,
41,11,N,H,,,,,,,,,,S,"FHA phosphopeptide ligands, 5-11, ELM|Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, dlbcl_duke_2017, nhl_bcgsc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985869-60985869, hg38,18:63318636-63318636","hg19,18:g.60985869T>G, hg38,18:g.63318636T>G",0.163,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
42,11,N,K,,,,,,,,,,S,"FHA phosphopeptide ligands, 5-11, ELM|Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,COSMIC,,,"hg38,18:63318634-63318634","hg38,18:g.63318634G>C",0.297,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
43,11,N,T,,,,,,,,,,S,"FHA phosphopeptide ligands, 5-11, ELM|Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985868-60985868","hg19,18:g.60985868T>G",0.249,,,,
44,11,N,Y,,,,,,,,,,S,"FHA phosphopeptide ligands, 5-11, ELM|Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985869-60985869, hg38,18:63318636-63318636","hg19,18:g.60985869T>A, hg38,18:g.63318636T>A",0.250,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, mediastinum","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",,
45,12,R,L,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,cBioPortal,lusc_tcga_pub,Lung Squamous Cell Carcinoma,"hg19,18:60985865-60985865","hg19,18:g.60985865C>A",0.456,,,,
46,12,R,P,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,18:60985865-60985865","hg19,18:g.60985865C>G",0.472,,,,
47,12,R,W,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 9-12, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985866-60985866, hg38,18:63318633-63318633","hg19,18:g.60985866G>A, hg38,18:g.63318633G>A",0.438,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
48,13,E,D,,,,,,,,,,S,,,"cBioPortal,COSMIC","ccle_broad_2019, lymphoma_cellline_msk_2020, mbn_mdacc_2013, msk_impact_2017, nhl_bcgsc_2013, pancan_pcawg_2020","Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985861-60985861, hg38,18:63318628-63318628","hg19,18:g.60985861C>A, hg19,18:g.60985861C>G, hg38,18:g.63318628C>G",0.023,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin, haematopoietic_and_lymphoid_tissue, tonsil","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",,
49,14,I,L,,,,,,,,,,S,,,"cBioPortal,COSMIC","msk_impact_2017, pancan_pcawg_2020",Mixed Cancer Types,"hg19,18:60985860-60985860, hg38,18:63318627-63318627","hg19,18:g.60985860T>G, hg38,18:g.63318627T>G",0.245,"haematopoietic_and_lymphoid_tissue, mediastinum","lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",,
50,14,I,M,,,,,,,,,,S,,,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985858-60985858, hg38,18:63318625-63318625","hg19,18:g.60985858T>C, hg38,18:g.63318625T>C",0.246,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
51,15,V,,,,,,,,,,,S,,,,,,,,,,,,
52,16,M,K,,,,,,,,,,S,,,"cBioPortal,COSMIC","dlbcl_duke_2017, hcc_mskimpact_2018, msk_impact_2017, msk_met_2021","Diffuse Large B-Cell Lymphoma, NOS, Hepatocellular Carcinoma, Mixed Cancer Types","hg19,18:60985853-60985853, hg38,18:63318620-63318620","hg19,18:g.60985853A>T, hg38,18:g.63318620A>T",0.163,"haematopoietic_and_lymphoid_tissue, liver","carcinoma, hepatocellular_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
53,16,M,L,,,,,,,,,,S,,,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985854-60985854, hg38,18:63318621-63318621","hg19,18:g.60985854T>G, hg38,18:g.63318621T>A",0.030,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
54,16,M,R,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318620-63318620","hg38,18:g.63318620A>C",0.115,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
55,16,M,T,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318620-63318620","hg38,18:g.63318620A>G",0.084,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
56,16,M,V,,,,,,,,,,S,,,"cBioPortal,COSMIC","dlbcl_dfci_2018, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985854-60985854, hg38,18:63318621-63318621","hg19,18:g.60985854T>C, hg38,18:g.63318621T>C",0.043,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
57,17,K,E,,,,,,,,,,S,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985851-60985851, hg38,18:63318618-63318618","hg19,18:g.60985851T>C, hg38,18:g.63318618T>C",0.120,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000040281000258,
58,17,K,M,,,,,,,,,,S,,,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,18:60985850-60985850, hg38,18:63318617-63318617","hg19,18:g.60985850T>A, hg38,18:g.63318617T>A",0.207,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,
59,17,K,N,,,,,,,,,,S,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985849-60985849, hg38,18:63318616-63318616","hg19,18:g.60985849C>G, hg38,18:g.63318616C>A, hg38,18:g.63318616C>G",0.112,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, abdomen, haematopoietic_and_lymphoid_tissue, breast, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",0.0000120836186410,
60,18,Y,F,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 18-21, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985847-60985847, hg38,18:63318614-63318614","hg19,18:g.60985847T>A, hg38,18:g.63318614T>A",0.163,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, tonsil","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",,
61,19,I,L,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 18-21, ELM",,cBioPortal,"dlbcl_duke_2017, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985845-60985845","hg19,18:g.60985845T>G",0.143,,,0.0000040299505928,
62,19,I,M,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 18-21, ELM",,COSMIC,,,"hg38,18:63318610-63318610","hg38,18:g.63318610G>C",0.276,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
63,20,H,Q,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 18-21, ELM",,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018, dlbcl_duke_2017, egc_msk_tp53_ccr_2022, mbn_mdacc_2013, pancan_pcawg_2020","Diffuse Large B-Cell Lymphoma, NOS, Esophagogastric Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985840-60985840, hg38,18:63318607-63318607","hg19,18:g.60985840A>C, hg19,18:g.60985840A>T, hg38,18:g.63318607A>C, hg38,18:g.63318607A>T",0.143,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",0.0000565519470027,
64,20,H,R,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 18-21, ELM",,COSMIC,,,"hg38,18:63318608-63318608","hg38,18:g.63318608T>C",0.120,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
65,20,H,Y,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 18-21, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985842-60985842","hg19,18:g.60985842G>A",0.155,,,,
66,21,Y,C,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 18-21, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985838-60985838, hg38,18:63318605-63318605","hg19,18:g.60985838T>C, hg38,18:g.63318605T>C",0.408,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
67,21,Y,H,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 18-21, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985839-60985839, hg38,18:63318606-63318606","hg19,18:g.60985839A>G, hg38,18:g.63318606A>G",0.178,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
68,21,Y,S,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 18-21, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985838-60985838, hg38,18:63318605-63318605","hg19,18:g.60985838T>G, hg38,18:g.63318605T>G",0.383,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
69,22,K,N,,,Ubq,,,,,,,S,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985834-60985834, hg38,18:63318601-63318601","hg19,18:g.60985834C>G, hg38,18:g.63318601C>G",0.224,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
70,22,K,R,,,Ubq,,,,,,,S,,,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985835-60985835, hg38,18:63318602-63318602","hg19,18:g.60985835T>C, hg38,18:g.63318602T>C",0.222,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
71,23,L,V,,,,,,,,,,S,,,cBioPortal,"mbn_mdacc_2013, pcnsl_mayo_2015","Mature B-Cell Neoplasms, Primary DLBCL of the central nervous system","hg19,18:60985833-60985833","hg19,18:g.60985833G>C",0.373,,,,
72,24,S,,,,,,,,,,,S,,,,,,,,,,,,
73,25,Q,K,,,,,,,,,,C,,,cBioPortal,ccrcc_dfci_2019,Renal Clear Cell Carcinoma,"hg19,18:60985827-60985827","hg19,18:g.60985827G>T",0.112,,,,
74,25,Q,L,,,,,,,,,,C,,,cBioPortal,"dlbc_broad_2012, dlbcl_dfci_2018","Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985826-60985826","hg19,18:g.60985826T>A",0.359,,,,
75,26,R,K,,,,,,,,,,C,,,COSMIC,,,"hg38,18:63318590-63318590","hg38,18:g.63318590C>T",0.112,breast,"carcinoma, HER-positive_carcinoma",,
76,27,G,D,,,,,,,,,,C,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985820-60985820, hg38,18:63318587-63318587","hg19,18:g.60985820C>T, hg38,18:g.63318587C>T",0.415,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
77,28,Y,F,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985817-60985817, hg38,18:63318584-63318584","hg19,18:g.60985817T>A, hg38,18:g.63318584T>A",0.172,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
78,28,Y,H,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,18:60985818-60985818, hg38,18:63318585-63318585","hg19,18:g.60985818A>G, hg38,18:g.63318585A>G",0.319,"haematopoietic_and_lymphoid_tissue, large_intestine, rectum","carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
79,28,Y,N,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,COSMIC,,,"hg38,18:63318585-63318585","hg38,18:g.63318585A>T",0.378,"skin, mucosal, female_genital_tract_(site_indeterminate)",malignant_melanoma,,
80,28,Y,S,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,COSMIC,,,"hg38,18:63318584-63318584","hg38,18:g.63318584T>G",0.304,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
81,29,E,A,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,cBioPortal,"dlbcl_dfci_2018, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985814-60985814","hg19,18:g.60985814T>G",0.084,,,,
82,29,E,D,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985813-60985813, hg38,18:63318580-63318580","hg19,18:g.60985813C>A, hg19,18:g.60985813C>G, hg38,18:g.63318580C>A, hg38,18:g.63318580C>G",0.041,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
83,29,E,K,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,18:60985815-60985815, hg38,18:63318582-63318582","hg19,18:g.60985815C>T, hg38,18:g.63318582C>T",0.090,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
84,29,E,Q,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985815-60985815, hg38,18:63318582-63318582","hg19,18:g.60985815C>G, hg38,18:g.63318582C>G",0.093,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, mesentery","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
85,30,W,C,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985810-60985810, hg38,18:63318577-63318577","hg19,18:g.60985810C>G, hg38,18:g.63318577C>G",0.285,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
86,31,D,A,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985808-60985808, hg38,18:63318575-63318575","hg19,18:g.60985808T>G, hg38,18:g.63318575T>G",0.071,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, skin","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma",,
87,31,D,E,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985807-60985807, hg38,18:63318574-63318574","hg19,18:g.60985807A>T, hg38,18:g.63318574A>C, hg38,18:g.63318574A>T",0.040,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
88,31,D,G,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC","dlbcl_dfci_2018, mbn_mdacc_2013, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985808-60985808, hg38,18:63318575-63318575","hg19,18:g.60985808T>C, hg38,18:g.63318575T>C",0.080,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
89,31,D,H,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985809-60985809, hg38,18:63318576-63318576","hg19,18:g.60985809C>G, hg38,18:g.63318576C>G",0.143,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, abdomen","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0001021754863979,0.0000319244030137
90,31,D,N,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mature B-Cell Neoplasms","hg19,18:60985809-60985809, hg38,18:63318576-63318576","hg19,18:g.60985809C>T, hg38,18:g.63318576C>T",0.077,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",0.0000042573119332,
91,32,A,T,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC",pptc_2019,Mixed Cancer Types,"hg19,18:60985806-60985806, hg38,18:63318573-63318573","hg19,18:g.60985806C>T, hg38,18:g.63318573C>T",0.039,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
92,32,A,V,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 28-32, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, nccrcc_genentech_2014","Mature B-Cell Neoplasms, Renal Non-Clear Cell Carcinoma","hg19,18:60985805-60985805, hg38,18:63318572-63318572","hg19,18:g.60985805G>A, hg38,18:g.63318572G>A",0.118,"haematopoietic_and_lymphoid_tissue, kidney","carcinoma, renal_cell_carcinoma_unclassified, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
93,33,G,A,,,,,,,,,,C,,,cBioPortal,"dlbcl_dfci_2018, mbn_mdacc_2013, msk_met_2021","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985802-60985802","hg19,18:g.60985802C>G",0.113,,,,
94,33,G,E,,,,,,,,,,C,,,"cBioPortal,COSMIC","mbn_mdacc_2013, pancan_pcawg_2020","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985802-60985802, hg38,18:63318569-63318569","hg19,18:g.60985802C>T, hg38,18:g.63318569C>T",0.089,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
95,33,G,R,,,,,,,,,,C,,,"cBioPortal,COSMIC","difg_glass_2019, dlbc_broad_2012, dlbcl_dfci_2018, mbn_mdacc_2013, msk_impact_2017","Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985803-60985803, hg38,18:63318570-63318570","hg19,18:g.60985803C>T, hg38,18:g.63318570C>G, hg38,18:g.63318570C>T",0.132,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",0.0000042805287309,
96,34,D,A,,,,,,,,,,C,,,COSMIC,,,"hg38,18:63318566-63318566","hg38,18:g.63318566T>G",0.130,"haematopoietic_and_lymphoid_tissue, liver","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, other, neoplasm",,
97,34,D,E,,,,,,,,,,C,,,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017, pancan_pcawg_2020","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985798-60985798, hg38,18:63318565-63318565","hg19,18:g.60985798A>T, hg38,18:g.63318565A>T",0.016,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, pelvis","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
98,34,D,G,,,,,,,,,,C,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,18:60985799-60985799, hg38,18:63318566-63318566","hg19,18:g.60985799T>C, hg38,18:g.63318566T>C",0.128,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
99,34,D,H,,,,,,,,,,C,,,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018, mbn_mdacc_2013, pan_origimed_2020","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985800-60985800, hg38,18:63318567-63318567","hg19,18:g.60985800C>G, hg38,18:g.63318567C>G",0.123,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,0.0000043412952689,
100,34,D,N,,,,,,,,,,C,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985800-60985800, hg38,18:63318567-63318567","hg19,18:g.60985800C>T, hg38,18:g.63318567C>T",0.057,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
101,34,D,V,,,,,,,,,,C,,,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985799-60985799","hg19,18:g.60985799T>A",0.124,,,,
102,35,V,L,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318564-63318564","hg38,18:g.63318564C>G",0.075,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
103,35,V,M,,,,,,,,,,D,,,"cBioPortal,COSMIC","ccle_broad_2019, lymphoma_cellline_msk_2020, mbn_mdacc_2013","Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985797-60985797, hg38,18:63318564-63318564","hg19,18:g.60985797C>T, hg38,18:g.63318564C>T",0.048,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000043915892283,
104,36,G,D,,,,,,,,,,D,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985793-60985793, hg38,18:63318560-63318560","hg19,18:g.60985793C>T, hg38,18:g.63318560C>T",0.048,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma",,
105,37,A,V,,,,,,,,,,D,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985790-60985790, hg38,18:63318557-63318557","hg19,18:g.60985790G>A, hg38,18:g.63318557G>A",0.082,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
106,38,A,,,,,,,,,,,D,,,,,,,,,,,,
107,39,P,A,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318552-63318552","hg38,18:g.63318552G>C",0.021,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
108,39,P,L,,,,,,,,,,D,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,18:60985784-60985784, hg38,18:63318551-63318551","hg19,18:g.60985784G>A, hg38,18:g.63318551G>A",0.089,skin,"carcinoma, basal_cell_carcinoma",,0.0000319529652352
109,39,P,S,,,,,,,,,,D,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60985785-60985785","hg19,18:g.60985785G>A",0.013,,,,
110,40,P,A,,,,,,,,,,D,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985782-60985782","hg19,18:g.60985782G>C",0.074,,,,
111,40,P,S,,,,,,,,,,D,,,cBioPortal,mds_iwg_2022,Myelodysplastic Syndromes,"hg19,18:60985782-60985782","hg19,18:g.60985782G>A",0.063,,,,
112,41,G,V,,,,,,,,,,D,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,18:60985778-60985778","hg19,18:g.60985778C>A",0.022,,,,
113,42,A,V,,,,,,,,,,D,,,cBioPortal,"ccle_broad_2019, lymphoma_cellline_msk_2020","Lymphoid, Mixed Cancer Types","hg19,18:60985775-60985775","hg19,18:g.60985775G>A",0.112,,,,
114,43,A,G,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318539-63318539","hg38,18:g.63318539G>C",0.061,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
115,43,A,T,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318540-63318540","hg38,18:g.63318540C>T",0.064,"breast, stomach","adenoma, carcinoma, carcinoma, ductal_carcinoma",0.0177831731704831,0.0057250687647924
116,43,A,V,,,,,,,,,,D,,,"cBioPortal,COSMIC","dlbcl_dfci_2018, skcm_dfci_2015","Cutaneous Melanoma, Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985772-60985772, hg38,18:63318539-63318539","hg19,18:g.60985772G>A, hg38,18:g.63318539G>A",0.048,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
117,44,P,A,,,,,,,,,,D,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985770-60985770","hg19,18:g.60985770G>C",0.050,,,,
118,44,P,L,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318536-63318536","hg38,18:g.63318536G>A",0.061,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
119,45,A,S,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318534-63318534","hg38,18:g.63318534C>A",0.038,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, follicular_lymphoma",0.0000046824371149,
120,45,A,T,,,,,,,,,,D,,,"cBioPortal,COSMIC","cll_iuopa_2015, dlbc_broad_2012, dlbcl_dfci_2018, msk_impact_2017","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985767-60985767, hg38,18:63318534-63318534","hg19,18:g.60985767C>T, hg38,18:g.63318534C>T",0.068,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
121,45,A,V,,,,,,,,,,D,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985766-60985766, hg38,18:63318533-63318533","hg19,18:g.60985766G>A, hg38,18:g.63318533G>A",0.086,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
122,46,P,A,,,,,,,,,,D,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985764-60985764, hg38,18:63318531-63318531","hg19,18:g.60985764G>C, hg38,18:g.63318531G>C",0.045,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000046673574356,
123,46,P,Q,,,,,,,,,,D,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,18:60985763-60985763","hg19,18:g.60985763G>T",0.129,,,,
124,46,P,S,,,,,,,,,,D,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985764-60985764, hg38,18:63318531-63318531","hg19,18:g.60985764G>A, hg38,18:g.63318531G>A",0.082,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
125,47,G,A,,,,,,,,,,D,,,"cBioPortal,COSMIC","mbn_mdacc_2013, pancan_pcawg_2020","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985760-60985760, hg38,18:63318527-63318527","hg19,18:g.60985760C>G, hg38,18:g.63318527C>G",0.066,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
126,47,G,D,,,,,,,,,,D,,,"cBioPortal,COSMIC","ccle_broad_2019, dlbcl_dfci_2018, mbn_mdacc_2013, msk_impact_2017, nhl_bcgsc_2013, pancan_pcawg_2020","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985760-60985760, hg38,18:63318527-63318527","hg19,18:g.60985760C>T, hg38,18:g.63318527C>T",0.048,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",0.0000048482967933,
127,47,G,S,,,,,,,,,,D,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,18:60985761-60985761, hg38,18:63318528-63318528","hg19,18:g.60985761C>T, hg38,18:g.63318528C>T",0.051,stomach,"carcinoma, adenocarcinoma",0.0000144295979914,0.0000319693094629
128,47,G,V,,,,,,,,,,D,,,"cBioPortal,COSMIC","dlbcl_dfci_2018, mbn_mdacc_2013, msk_met_2021","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985760-60985760, hg38,18:63318527-63318527","hg19,18:g.60985760C>A, hg38,18:g.63318527C>A",0.048,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,0.0000048482967933,
129,48,I,F,,,,,,,,,,D,,,"cBioPortal,COSMIC","ccle_broad_2019, lymphoma_cellline_msk_2020, nhl_bcgsc_2013","Lymphoid, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985758-60985758, hg38,18:63318525-63318525","hg19,18:g.60985758T>A, hg38,18:g.63318525T>A",0.055,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
130,48,I,M,,,,,,,,,,D,,,"cBioPortal,COSMIC","ccle_broad_2019, mbn_mdacc_2013","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985756-60985756, hg38,18:63318523-63318523","hg19,18:g.60985756G>C, hg38,18:g.63318523G>C",0.058,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, marginal_zone_lymphoma",,
131,48,I,S,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318524-63318524","hg38,18:g.63318524A>C",0.098,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
132,48,I,T,,,,,,,,,,D,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,18:60985757-60985757, hg38,18:63318524-63318524","hg19,18:g.60985757A>G, hg38,18:g.63318524A>G",0.090,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, mesentery","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
133,48,I,V,,,,,,,,,,D,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985758-60985758, hg38,18:63318525-63318525","hg19,18:g.60985758T>C, hg38,18:g.63318525T>C",0.038,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
134,49,F,C,,,,,,,,,,D,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985754-60985754, hg38,18:63318521-63318521","hg19,18:g.60985754A>C, hg38,18:g.63318521A>C",0.042,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
135,49,F,I,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318522-63318522","hg38,18:g.63318522A>T",0.031,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
136,49,F,L,,,,,,,,,,D,,,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018, mbn_mdacc_2013, nhl_bcgsc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Non-Hodgkin Lymphoma","hg19,18:60985753-60985753, hg19,18:60985755-60985755, hg38,18:63318520-63318520, hg38,18:63318522-63318522","hg19,18:g.60985753G>C, hg19,18:g.60985755A>G, hg38,18:g.63318520G>C, hg38,18:g.63318522A>G","0.024, 0.066",haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
137,49,F,S,,,,,,,,,,D,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985754-60985754, hg38,18:63318521-63318521","hg19,18:g.60985754A>G, hg38,18:g.63318521A>G",0.021,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
138,49,F,V,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318522-63318522","hg38,18:g.63318522A>C",0.036,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
139,50,S,P,,,,,,,,,,C,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985752-60985752, hg38,18:63318519-63318519","hg19,18:g.60985752A>G, hg38,18:g.63318519A>G",0.159,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
140,51,S,F,,,,,,,,,,C,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,18:60985748-60985748, hg38,18:63318515-63318515","hg19,18:g.60985748G>A, hg38,18:g.63318515G>A",0.042,skin,"carcinoma, basal_cell_carcinoma",,
141,51,S,P,,,,,,,,,,C,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985749-60985749, hg38,18:63318516-63318516","hg19,18:g.60985749A>G, hg38,18:g.63318516A>G",0.025,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",0.0000102871133331,
142,51,S,Y,,,,,,,,,,C,,,COSMIC,,,"hg38,18:63318515-63318515","hg38,18:g.63318515G>T",0.034,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
143,52,Q,H,,,,,,,,,,C,,,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,18:60985744-60985744, hg38,18:63318511-63318511","hg19,18:g.60985744C>G, hg38,18:g.63318511C>G",0.046,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma",,
144,52,Q,P,,,,,,,,,,C,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985745-60985745, hg38,18:63318512-63318512","hg19,18:g.60985745T>G, hg38,18:g.63318512T>G",0.054,"haematopoietic_and_lymphoid_tissue, skin","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
145,52,Q,R,,,,,,,,,,C,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985745-60985745, hg38,18:63318512-63318512","hg19,18:g.60985745T>C, hg38,18:g.63318512T>C",0.056,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, mediastinum","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",,
146,53,P,A,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985743-60985743","hg19,18:g.60985743G>C",0.085,,,,
147,53,P,L,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985742-60985742","hg19,18:g.60985742G>A",0.028,,,,
148,53,P,S,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, lymphoma_cellline_msk_2020, mbn_mdacc_2013, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985743-60985743, hg38,18:63318510-63318510","hg19,18:g.60985743G>A, hg38,18:g.63318510G>A",0.087,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, mesentery","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma",,
149,53,P,T,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,COSMIC,,,"hg38,18:63318510-63318510","hg38,18:g.63318510G>T",0.043,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
150,54,G,R,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,"cBioPortal,COSMIC",prad_msk_2019,Prostate,"hg19,18:60985740-60985740, hg38,18:63318507-63318507","hg19,18:g.60985740C>T, hg38,18:g.63318507C>T",0.092,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
151,55,H,L,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,COSMIC,,,"hg38,18:63318503-63318503","hg38,18:g.63318503T>A",0.038,"haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
152,55,H,N,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,COSMIC,,,"hg38,18:63318504-63318504","hg38,18:g.63318504G>T",0.044,"haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma",,
153,55,H,P,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,18:60985736-60985736","hg19,18:g.60985736T>G",0.028,,,,
154,55,H,Q,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,COSMIC,,,"hg38,18:63318502-63318502","hg38,18:g.63318502G>C",0.081,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
155,55,H,R,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,COSMIC,,,"hg38,18:63318503-63318503","hg38,18:g.63318503T>C",0.040,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
156,56,T,M,P,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,cBioPortal,"dlbcl_duke_2017, mbn_mdacc_2013, pancan_pcawg_2020, prostate_pcbm_swiss_2019","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types, Prostate","hg19,18:60985733-60985733","hg19,18:g.60985733G>A",0.032,,,,
157,56,T,R,P,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985733-60985733","hg19,18:g.60985733G>C",0.035,,,0.0000061358727665,
158,56,T,S,P,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,cBioPortal,"dlbc_broad_2012, dlbcl_dfci_2018","Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985734-60985734","hg19,18:g.60985734T>A",0.037,,,,
159,57,P,A,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,COSMIC,,,"hg38,18:63318498-63318498","hg38,18:g.63318498G>C",0.034,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
160,57,P,H,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021, prad_pik3r1_msk_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,18:60985730-60985730","hg19,18:g.60985730G>T",0.072,,,,
161,57,P,L,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018","Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985730-60985730, hg38,18:63318497-63318497","hg19,18:g.60985730G>A, hg38,18:g.63318497G>A",0.057,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
162,57,P,S,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985731-60985731, hg38,18:63318498-63318498","hg19,18:g.60985731G>A, hg38,18:g.63318498G>A",0.050,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
163,58,H,L,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,COSMIC,,,"hg38,18:63318494-63318494","hg38,18:g.63318494T>A",0.031,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
164,58,H,N,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,COSMIC,,,"hg38,18:63318495-63318495","hg38,18:g.63318495G>T",0.007,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
165,58,H,P,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985727-60985727","hg19,18:g.60985727T>G",0.042,,,,
166,58,H,Q,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985726-60985726, hg38,18:63318493-63318493","hg19,18:g.60985726A>C, hg38,18:g.63318493A>C, hg38,18:g.63318493A>T",0.034,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, soft_tissue","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
167,58,H,R,,,,,,,,,,C,"WW domain ligands, 53-58, ELM",,COSMIC,,,"hg38,18:63318494-63318494","hg38,18:g.63318494T>C",0.025,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
168,59,P,A,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, dlbc_broad_2012, dlbcl_dfci_2018, mbn_mdacc_2013, msk_ch_2020, msk_met_2021, nhl_bcgsc_2013, pancan_pcawg_2020","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985725-60985725, hg38,18:63318492-63318492","hg19,18:g.60985725G>C, hg38,18:g.63318492G>C",0.098,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, soft_tissue","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
169,59,P,L,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, mbn_mdacc_2013, msk_impact_2017, nhl_bcgsc_2013","Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985724-60985724, hg38,18:63318491-63318491","hg19,18:g.60985724G>A, hg38,18:g.63318491G>A",0.091,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, tonsil","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
170,59,P,R,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985724-60985724","hg19,18:g.60985724G>C",0.111,,,,
171,59,P,S,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, mbn_mdacc_2013, msk_impact_2017, nhl_bcgsc_2013, pancan_pcawg_2020","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985725-60985725, hg38,18:63318492-63318492","hg19,18:g.60985725G>A, hg38,18:g.63318492G>A",0.101,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, soft_tissue","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma",,
172,59,P,T,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, lymphoma_cellline_msk_2020","Lymphoid, Mixed Cancer Types","hg19,18:60985725-60985725, hg38,18:63318492-63318492","hg19,18:g.60985725G>T, hg38,18:g.63318492G>T",0.091,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
173,60,A,D,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985721-60985721, hg38,18:63318488-63318488","hg19,18:g.60985721G>T, hg38,18:g.63318488G>T",0.147,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
174,60,A,G,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,COSMIC,,,"hg38,18:63318488-63318488","hg38,18:g.63318488G>C",0.050,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
175,60,A,T,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_met_2021, prad_msk_stopsack_2021","Mature B-Cell Neoplasms, Mixed Cancer Types, Prostate Adenocarcinoma","hg19,18:60985722-60985722, hg38,18:63318489-63318489","hg19,18:g.60985722C>T, hg38,18:g.63318489C>T",0.106,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
176,60,A,V,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, dlbcl_duke_2017, mbn_mdacc_2013, nhl_bcgsc_2013, pancan_pcawg_2020","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985721-60985721, hg38,18:63318488-63318488","hg19,18:g.60985721G>A, hg38,18:g.63318488G>A",0.040,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
177,61,A,T,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, mbn_mdacc_2013, mel_dfci_2019, pan_origimed_2020, stad_tcga_pan_can_atlas_2018","Mature B-Cell Neoplasms, Melanoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,18:60985719-60985719, hg38,18:63318486-63318486","hg19,18:g.60985719C>T, hg38,18:g.63318486C>T",0.064,"haematopoietic_and_lymphoid_tissue, lung, stomach","carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000158596736079,0.0000638814360547
178,61,A,V,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,cBioPortal,"mbn_mdacc_2013, msk_met_2021","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985718-60985718","hg19,18:g.60985718G>A",0.045,,,,
179,62,S,F,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985715-60985715, hg38,18:63318482-63318482","hg19,18:g.60985715G>A, hg38,18:g.63318482G>A",0.037,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, malignant_histiocytosis",0.0001324433142615,0.0001278118609407
180,62,S,P,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985716-60985716","hg19,18:g.60985716A>G",0.024,,,,
181,62,S,Y,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985715-60985715","hg19,18:g.60985715G>T",0.039,,,0.0000088295542841,
182,63,R,,,,,,,,,,,C,"USP7 binding motif, 59-63, ELM",,,,,,,,,,,
183,64,D,G,,,,,,,,,,C,,,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_access_2021, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985709-60985709, hg38,18:63318476-63318476","hg19,18:g.60985709T>C, hg38,18:g.63318476T>C",0.057,"haematopoietic_and_lymphoid_tissue, retroperitoneum","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
184,65,P,A,,,,,,,,,,C,,,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985707-60985707, hg38,18:63318474-63318474","hg19,18:g.60985707G>C, hg38,18:g.63318474G>C",0.032,"haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma",,
185,65,P,L,,,,,,,,,,C,,,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,18:60985706-60985706","hg19,18:g.60985706G>A",0.028,,,0.0000000000000000,
186,65,P,Q,,,,,,,,,,C,,,COSMIC,,,"hg38,18:63318473-63318473","hg38,18:g.63318473G>T",0.026,large_intestine,"carcinoma, adenocarcinoma",,
187,65,P,S,,,,,,,,,,C,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985707-60985707, hg38,18:63318474-63318474","hg19,18:g.60985707G>A, hg38,18:g.63318474G>A",0.029,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",0.0000000000000000,
188,65,P,T,,,,,,,,,,C,,,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985707-60985707","hg19,18:g.60985707G>T",0.029,,,,
189,66,V,A,,,,,,,,,,C,,,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985703-60985703","hg19,18:g.60985703A>G",0.058,,,,
190,66,V,G,,,,,,,,,,C,,,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985703-60985703","hg19,18:g.60985703A>C",0.082,,,,
191,66,V,I,,,,,,,,,,C,,,COSMIC,,,"hg38,18:63318471-63318471","hg38,18:g.63318471C>T",0.064,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, follicular_lymphoma",0.0000333993899045,
192,66,V,L,,,,,,,,,,C,,,COSMIC,,,"hg38,18:63318471-63318471","hg38,18:g.63318471C>G",0.079,"haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
193,67,A,T,,,,,,,,,,D,"WW domain ligands, 67-72, ELM|FHA phosphopeptide ligands, 67-73, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, pog570_bcgsc_2020","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985701-60985701, hg38,18:63318468-63318468","hg19,18:g.60985701C>T, hg38,18:g.63318468C>T",0.036,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000000000000000,
194,67,A,V,,,,,,,,,,D,"WW domain ligands, 67-72, ELM|FHA phosphopeptide ligands, 67-73, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985700-60985700, hg38,18:63318467-63318467","hg19,18:g.60985700G>A, hg38,18:g.63318467G>A",0.074,"haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",0.0000102268311141,0.0000319345979434
195,68,R,G,,,,,,,,,,D,"WW domain ligands, 67-72, ELM|FHA phosphopeptide ligands, 67-73, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985698-60985698","hg19,18:g.60985698T>C",0.090,,,0.0000206007169049,
196,68,R,M,,,,,,,,,,D,"WW domain ligands, 67-72, ELM|FHA phosphopeptide ligands, 67-73, ELM",,COSMIC,,,"hg38,18:63318464-63318464","hg38,18:g.63318464C>A",0.090,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
197,69,T,A,P,,,,,,,,,D,"WW domain ligands, 67-72, ELM|FHA phosphopeptide ligands, 67-73, ELM",,COSMIC,,,"hg38,18:63318462-63318462","hg38,18:g.63318462T>C",0.061,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
198,69,T,I,P,,,,,,,,,D,"WW domain ligands, 67-72, ELM|FHA phosphopeptide ligands, 67-73, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985694-60985694","hg19,18:g.60985694G>A",0.045,,,,
199,69,T,P,P,,,,,,,,,D,"WW domain ligands, 67-72, ELM|FHA phosphopeptide ligands, 67-73, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, mbn_mdacc_2013, msk_impact_2017, nhl_bcgsc_2013","Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985695-60985695, hg38,18:63318462-63318462","hg19,18:g.60985695T>G, hg38,18:g.63318462T>G",0.060,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
200,70,S,A,P,,,,,,,,,D,"WW domain ligands, 67-72, ELM|FHA phosphopeptide ligands, 67-73, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985692-60985692","hg19,18:g.60985692A>C",0.050,,,,
201,70,S,P,P,,,,,,,,,D,"WW domain ligands, 67-72, ELM|FHA phosphopeptide ligands, 67-73, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985692-60985692","hg19,18:g.60985692A>G",0.069,,,,
202,70,S,W,P,,,,,,,,,D,"WW domain ligands, 67-72, ELM|FHA phosphopeptide ligands, 67-73, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60985691-60985691","hg19,18:g.60985691G>C",0.182,,,,
203,71,P,A,,,,,,,,,,D,"WW domain ligands, 67-72, ELM|WW domain ligands, 71-76, ELM|FHA phosphopeptide ligands, 67-73, ELM",,COSMIC,,,"hg38,18:63318456-63318456","hg38,18:g.63318456G>C",0.098,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
204,71,P,L,,,,,,,,,,D,"WW domain ligands, 67-72, ELM|WW domain ligands, 71-76, ELM|FHA phosphopeptide ligands, 67-73, ELM",,COSMIC,,,"hg38,18:63318455-63318455","hg38,18:g.63318455G>A",0.120,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, squamous_cell_carcinoma",,
205,71,P,S,,,,,,,,,,D,"WW domain ligands, 67-72, ELM|WW domain ligands, 71-76, ELM|FHA phosphopeptide ligands, 67-73, ELM",,COSMIC,,,"hg38,18:63318456-63318456","hg38,18:g.63318456G>A",0.100,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",,0.0000319693094629
206,71,P,T,,,,,,,,,,D,"WW domain ligands, 67-72, ELM|WW domain ligands, 71-76, ELM|FHA phosphopeptide ligands, 67-73, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985689-60985689, hg38,18:63318456-63318456","hg19,18:g.60985689G>T, hg38,18:g.63318456G>T",0.113,"haematopoietic_and_lymphoid_tissue, central_nervous_system","lymphoid_neoplasm, primary_central_nervous_system_lymphoma",,
207,72,L,V,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 67-72, ELM|WW domain ligands, 71-76, ELM|FHA phosphopeptide ligands, 67-73, ELM|SH3 ligand, 72-78, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985686-60985686","hg19,18:g.60985686G>C",0.084,,,,
208,73,Q,E,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|FHA phosphopeptide ligands, 67-73, ELM|SH3 ligand, 72-78, ELM",,cBioPortal,dlbcl_dfci_2018,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985683-60985683","hg19,18:g.60985683G>C",0.112,,,,
209,73,Q,H,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|FHA phosphopeptide ligands, 67-73, ELM|SH3 ligand, 72-78, ELM",,cBioPortal,"ccle_broad_2019, pog570_bcgsc_2020",Mixed Cancer Types,"hg19,18:60985681-60985681","hg19,18:g.60985681C>A, hg19,18:g.60985681C>G",0.043,,,,
210,73,Q,L,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|FHA phosphopeptide ligands, 67-73, ELM|SH3 ligand, 72-78, ELM",,cBioPortal,"dlbcl_dfci_2018, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985682-60985682","hg19,18:g.60985682T>A",0.053,,,,
211,73,Q,P,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|FHA phosphopeptide ligands, 67-73, ELM|SH3 ligand, 72-78, ELM",,COSMIC,,,"hg38,18:63318449-63318449","hg38,18:g.63318449T>G",0.048,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma",,
212,73,Q,R,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|FHA phosphopeptide ligands, 67-73, ELM|SH3 ligand, 72-78, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985682-60985682","hg19,18:g.60985682T>C",0.051,,,,
213,74,T,A,P,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|SH3 ligand, 72-78, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985680-60985680, hg38,18:63318445-63318447, hg38,18:63318447-63318447","hg19,18:g.60985680T>C, hg38,18:g.63318445_63318447delinsAGC, hg38,18:g.63318447T>C",0.043,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
214,74,T,I,P,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|SH3 ligand, 72-78, ELM",,COSMIC,,,"hg38,18:63318446-63318446","hg38,18:g.63318446G>A",0.050,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000000000000000,
215,74,T,N,P,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|SH3 ligand, 72-78, ELM",,COSMIC,,,"hg38,18:63318446-63318446","hg38,18:g.63318446G>T",0.077,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
216,74,T,S,P,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|SH3 ligand, 72-78, ELM",,COSMIC,,,"hg38,18:63318446-63318446, hg38,18:63318447-63318447","hg38,18:g.63318446G>C, hg38,18:g.63318447T>A","0.046, 0.066",haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
217,75,P,A,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|SH3 ligand, 72-78, ELM",,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,18:60985677-60985677, hg38,18:63318444-63318444","hg19,18:g.60985677G>C, hg38,18:g.63318444G>C",0.054,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
218,76,A,P,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|SH3 ligand, 72-78, ELM",,COSMIC,,,"hg38,18:63318441-63318441","hg38,18:g.63318441C>G",0.071,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
219,76,A,S,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|SH3 ligand, 72-78, ELM",,"cBioPortal,COSMIC",dlbcl_dfci_2018,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985674-60985674, hg38,18:63318441-63318441","hg19,18:g.60985674C>A, hg38,18:g.63318441C>A",0.047,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",,
220,76,A,T,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|SH3 ligand, 72-78, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985674-60985674, hg38,18:63318441-63318441","hg19,18:g.60985674C>T, hg38,18:g.63318441C>T",0.058,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, B_cell_lymphoma_unspecified, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma",,
221,76,A,V,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|WW domain ligands, 71-76, ELM|SH3 ligand, 72-78, ELM",,COSMIC,,,"hg38,18:63318440-63318440","hg38,18:g.63318440G>A",0.065,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
222,77,A,D,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|SH3 ligand, 72-78, ELM",,COSMIC,,,"hg38,18:63318437-63318437","hg38,18:g.63318437G>T",0.034,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
223,77,A,G,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|SH3 ligand, 72-78, ELM",,COSMIC,,,"hg38,18:63318437-63318437","hg38,18:g.63318437G>C",0.028,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
224,77,A,T,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|SH3 ligand, 72-78, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985671-60985671","hg19,18:g.60985671C>T",0.065,,,,
225,77,A,V,,,,,,,,,,D,"Cks1 ligand, 72-77, ELM|SH3 ligand, 72-78, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985670-60985670, hg38,18:63318437-63318437","hg19,18:g.60985670G>A, hg38,18:g.63318437G>A",0.043,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, abdomen","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000098229897252,0.0000319795330988
226,78,P,,,,,,,,,,,D,"SH3 ligand, 72-78, ELM",,,,,,,,,,,
227,79,G,,,,,,,,,,,D,,,,,,,,,,,,
228,80,A,V,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318428-63318428","hg38,18:g.63318428G>A",0.057,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000090038176187,
229,81,A,V,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318425-63318425","hg38,18:g.63318425G>A",0.063,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
230,82,A,E,,,,,,,,,,D,,,COSMIC,,,"hg38,18:63318422-63318422","hg38,18:g.63318422G>T",0.008,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
231,82,A,T,,,,,,,,,,D,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,18:60985656-60985656, hg38,18:63318423-63318423","hg19,18:g.60985656C>T, hg38,18:g.63318423C>T",0.023,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, extranodal","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
232,83,G,E,,,,,,,,,,D,,,"cBioPortal,COSMIC","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,18:60985652-60985652, hg38,18:63318419-63318419","hg19,18:g.60985652C>T, hg38,18:g.63318419C>T",0.076,"central_nervous_system, brain","glioma, oligodendroglioma_Grade_III, anaplastic",0.0000080694619283,
233,84,P,L,,,,,,,,,,D,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985649-60985649","hg19,18:g.60985649G>A",0.070,,,,
234,85,A,G,,,,,,,,,,D,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,COSMIC,,,"hg38,18:63318413-63318413","hg38,18:g.63318413G>C",0.022,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
235,85,A,P,,,,,,,,,,D,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,COSMIC,,,"hg38,18:63318414-63318414","hg38,18:g.63318414C>G",0.062,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
236,85,A,S,,,,,,,,,,D,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,cBioPortal,"gbc_mskcc_2022, msk_met_2021, pan_origimed_2020","Gallbladder Cancer, Mixed Cancer Types","hg19,18:60985647-60985647","hg19,18:g.60985647C>A",0.042,,,,
237,85,A,T,,,,,,,,,,D,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC","gbm_tcga_pub, mbn_mdacc_2013, msk_impact_2017","Glioblastoma Multiforme, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985647-60985647, hg38,18:63318414-63318414","hg19,18:g.60985647C>T, hg38,18:g.63318414C>T",0.049,"haematopoietic_and_lymphoid_tissue, pelvis","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
238,85,A,V,,,,,,,,,,D,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985646-60985646, hg38,18:63318413-63318413","hg19,18:g.60985646G>A, hg38,18:g.63318413G>A",0.028,"haematopoietic_and_lymphoid_tissue, soft_tissue","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
239,86,L,F,,,,,,,,,,D,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC","dlbcl_dfci_2018, dlbcl_duke_2017, lymphoma_cellline_msk_2020, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Lymphoid, Mature B-Cell Neoplasms","hg19,18:60985644-60985644, hg38,18:63318411-63318411","hg19,18:g.60985644G>A, hg38,18:g.63318411G>A",0.082,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, soft_tissue","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
240,86,L,V,,,,,,,,,,D,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, dlbc_broad_2012, dlbcl_dfci_2018, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985644-60985644, hg38,18:63318411-63318411","hg19,18:g.60985644G>C, hg38,18:g.63318411G>C",0.073,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
241,87,S,C,P,,,,,,,,,C,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,COSMIC,,,"hg38,18:63318408-63318408","hg38,18:g.63318408T>A",0.055,"haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
242,87,S,N,P,,,,,,,,,C,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985640-60985640, hg38,18:63318407-63318407","hg19,18:g.60985640C>T, hg38,18:g.63318407C>T",0.085,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
243,87,S,R,P,,,,,,,,,C,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985639-60985639, hg38,18:63318406-63318406","hg19,18:g.60985639G>T, hg38,18:g.63318406G>C, hg38,18:g.63318406G>T",0.066,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, retroperitoneum","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000059114931249,
244,87,S,T,P,,,,,,,,,C,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985640-60985640, hg38,18:63318407-63318407","hg19,18:g.60985640C>G, hg38,18:g.63318407C>G",0.056,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, skin","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
245,88,P,Q,,,,,,,,,,C,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,COSMIC,,,"hg38,18:63318404-63318404","hg38,18:g.63318404G>T",0.121,large_intestine,"carcinoma, adenocarcinoma",,
246,88,P,R,,,,,,,,,,C,"WW domain ligands, 84-89, ELM|MYND domain binding motif., 84-88, ELM|SH3 ligand, 85-91, ELM",,cBioPortal,"ccle_broad_2019, mbn_mdacc_2013","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985637-60985637","hg19,18:g.60985637G>C",0.139,,,0.0000340271082629,
247,89,V,A,,,,,,,,,,C,"WW domain ligands, 84-89, ELM|SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985634-60985634, hg38,18:63318401-63318401","hg19,18:g.60985634A>G, hg38,18:g.63318401A>G",0.025,"haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000051652892562,
248,90,P,S,,,,,,,,,,C,"SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC","difg_glass_2019, dlbc_broad_2012, dlbcl_dfci_2018, dlbcl_duke_2017, mbn_mdacc_2013, pan_origimed_2020","Diffuse Glioma, Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985632-60985632, hg38,18:63318399-63318399","hg19,18:g.60985632G>A, hg38,18:g.63318399G>A",0.066,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
249,90,P,T,,,,,,,,,,C,"SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985632-60985632, hg38,18:63318399-63318399","hg19,18:g.60985632G>T, hg38,18:g.63318399G>T",0.098,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
250,91,P,A,,,,,,,,,,C,"SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985629-60985629, hg38,18:63318396-63318396","hg19,18:g.60985629G>C, hg38,18:g.63318396G>C",0.056,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, spleen","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
251,91,P,H,,,,,,,,,,C,"SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,18:60985628-60985628, hg38,18:63318395-63318395","hg19,18:g.60985628G>T, hg38,18:g.63318395G>T",0.076,"haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
252,91,P,L,,,,,,,,,,C,"SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985628-60985628, hg38,18:63318395-63318395","hg19,18:g.60985628G>A, hg38,18:g.63318395G>A",0.037,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
253,91,P,R,,,,,,,,,,C,"SH3 ligand, 85-91, ELM",,COSMIC,,,"hg38,18:63318395-63318395","hg38,18:g.63318395G>C",0.087,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
254,91,P,S,,,,,,,,,,C,"SH3 ligand, 85-91, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, dlbcl_duke_2017, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985629-60985629, hg38,18:63318396-63318396","hg19,18:g.60985629G>A, hg38,18:g.63318396G>A",0.050,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, malignant_histiocytosis",,
255,92,V,E,,,,,,,,,,S,,,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985625-60985625","hg19,18:g.60985625A>T",0.174,,,,
256,92,V,G,,,,,,,,,,S,,,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985625-60985625","hg19,18:g.60985625A>C",0.180,,,,
257,92,V,L,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,18:60985626-60985626","hg19,18:g.60985626C>G",0.056,,,,
258,92,V,M,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318393-63318393","hg38,18:g.63318393C>T",0.080,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
259,93,V,I,,,,,,,,,,S,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985623-60985623, hg38,18:63318390-63318390","hg19,18:g.60985623C>T, hg38,18:g.63318390C>T",0.087,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
260,93,V,L,,,,,,,,,,S,,,"cBioPortal,COSMIC","dlbcl_duke_2017, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985623-60985623, hg38,18:63318390-63318390","hg19,18:g.60985623C>G, hg38,18:g.63318390C>G",0.109,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, spleen","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
261,94,H,Y,,,,,,,,,,S,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985620-60985620, hg38,18:63318387-63318387","hg19,18:g.60985620G>A, hg38,18:g.63318387G>A",0.158,"haematopoietic_and_lymphoid_tissue, mediastinum","lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",,
262,95,L,M,,,,,,,,,,S,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985617-60985617","hg19,18:g.60985617G>T",0.064,,,,
263,95,L,Q,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318383-63318383","hg38,18:g.63318383A>T",0.024,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
264,95,L,V,,,,,,,,,,S,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,18:60985617-60985617","hg19,18:g.60985617G>C",0.022,,,0.0000045489282725,
265,96,T,I,,,,,,,,,,S,,,cBioPortal,"mbn_mdacc_2013, skcm_tcga, skcm_tcga_pub_2015","Cutaneous Melanoma, Mature B-Cell Neoplasms","hg19,18:60985612-60985613, hg19,18:60985613-60985613","hg19,18:g.60985612_60985613delinsAA, hg19,18:g.60985613G>A",0.135,,,,
266,97,L,,,,,,,,,,,S,,,,,,,,,,,,
267,98,R,C,,,,,,,,,,S,,,"cBioPortal,COSMIC","ccle_broad_2019, msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,18:60985608-60985608, hg38,18:63318375-63318375","hg19,18:g.60985608G>A, hg38,18:g.63318375G>A",0.297,lung,"carcinoma, adenocarcinoma",,
268,98,R,H,,,,,,,,,,S,,,"cBioPortal,COSMIC","ccle_broad_2019, luad_tcga_pan_can_atlas_2018, mbn_mdacc_2013, mixed_allen_2018, msk_impact_2017, nsclc_tcga_broad_2016, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer, Stomach Adenocarcinoma","hg19,18:60985607-60985607, hg38,18:63318374-63318374","hg19,18:g.60985607C>T, hg38,18:g.63318374C>T",0.224,"haematopoietic_and_lymphoid_tissue, mediastinum, lung, stomach","carcinoma, adenocarcinoma, lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",0.0000000000000000,
269,99,Q,H,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318370-63318370","hg38,18:g.63318370C>G",0.041,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
270,100,A,S,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60985602-60985602","hg19,18:g.60985602C>A",0.292,,,,
271,101,G,A,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318365-63318365","hg38,18:g.63318365C>G",0.375,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
272,101,G,V,,,,,,,,,,S,,,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985598-60985598","hg19,18:g.60985598C>A",0.492,,,,
273,102,D,A,,,,,,,,,,S,,,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985595-60985595","hg19,18:g.60985595T>G",0.459,,,,
274,102,D,E,,,,,,,,,,S,,,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985594-60985594, hg38,18:63318361-63318361","hg19,18:g.60985594G>C, hg38,18:g.63318361G>C, hg38,18:g.63318361G>T",0.280,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
275,102,D,G,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318362-63318362","hg38,18:g.63318362T>C",0.455,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
276,102,D,N,,,,,,,,,,S,,,"cBioPortal,COSMIC","egc_msk_2017, egc_msk_tp53_ccr_2022, egc_mskcc_2020, msk_impact_2017","Esophagogastric Adenocarcinoma, Esophagus/Stomach, Mixed Cancer Types","hg19,18:60985596-60985596, hg38,18:63318363-63318363","hg19,18:g.60985596C>T, hg38,18:g.63318363C>T",0.368,oesophagus,"carcinoma, adenocarcinoma",0.0000083623227188,
277,103,D,H,,,,,,,,,,S,,,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985593-60985593","hg19,18:g.60985593C>G",0.248,,,0.0000124605416182,
278,103,D,N,,,,,,,,,,S,,,"cBioPortal,COSMIC","mbn_mdacc_2013, pancan_pcawg_2020","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985593-60985593, hg38,18:63318360-63318360","hg19,18:g.60985593C>T, hg38,18:g.63318360C>T",0.195,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
279,103,D,Y,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60985593-60985593","hg19,18:g.60985593C>A",0.332,,,,
280,104,F,L,,,,,,,,,,S,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985588-60985588, hg38,18:63318355-63318355, hg38,18:63318357-63318357","hg19,18:g.60985588G>C, hg38,18:g.63318355G>C, hg38,18:g.63318357A>G","0.070, 0.168","haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
281,104,F,Y,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318356-63318356","hg38,18:g.63318356A>T",0.312,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
282,105,S,F,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318353-63318353","hg38,18:g.63318353G>A",0.219,"haematopoietic_and_lymphoid_tissue, testis","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000081637984521,
283,105,S,P,,,,,,,,,,S,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,18:60985587-60985587, hg38,18:63318354-63318354","hg19,18:g.60985587A>G, hg38,18:g.63318354A>G",0.215,"breast, kidney","carcinoma, ER-positive_carcinoma, carcinoma, clear_cell_renal_cell_carcinoma",0.0000206502345867,
284,106,R,H,,,,,,,,,,S,"NRD cleavage site, 106-108, ELM|di Arginine retention/retrieving signal, 106-108, ELM",,"cBioPortal,COSMIC","egc_msk_2017, msk_impact_2017, tmb_mskcc_2018","Esophagogastric Adenocarcinoma, Mixed Cancer Types","hg19,18:60985583-60985583, hg38,18:63318350-63318350","hg19,18:g.60985583C>T, hg38,18:g.63318350C>T",0.196,stomach,"carcinoma, carcinoma, adenocarcinoma",,
285,106,R,L,,,,,,,,,,S,"NRD cleavage site, 106-108, ELM|di Arginine retention/retrieving signal, 106-108, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,18:60985583-60985583","hg19,18:g.60985583C>A",0.195,,,,
286,107,R,H,,,,,,,,,,S,"NRD cleavage site, 106-108, ELM|PCSK cleavage site, 107-111, ELM|di Arginine retention/retrieving signal, 106-108, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985580-60985580, hg38,18:63318347-63318347","hg19,18:g.60985580C>T, hg38,18:g.63318347C>T",0.210,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
287,107,R,L,,,,,,,,,,S,"NRD cleavage site, 106-108, ELM|PCSK cleavage site, 107-111, ELM|di Arginine retention/retrieving signal, 106-108, ELM",,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,18:60985580-60985580, hg38,18:63318347-63318347","hg19,18:g.60985580C>A, hg38,18:g.63318347C>A",0.100,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, follicular_lymphoma",,
288,108,Y,C,,,,,,,,,,S,"NRD cleavage site, 106-108, ELM|PCSK cleavage site, 107-111, ELM|di Arginine retention/retrieving signal, 106-108, ELM|di Arginine retention/retrieving signal, 108-110, ELM",,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018, mbn_mdacc_2013, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985577-60985577, hg38,18:63318344-63318344","hg19,18:g.60985577T>C, hg38,18:g.63318344T>C",0.407,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, retroperitoneum","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
289,108,Y,F,,,,,,,,,,S,"NRD cleavage site, 106-108, ELM|PCSK cleavage site, 107-111, ELM|di Arginine retention/retrieving signal, 106-108, ELM|di Arginine retention/retrieving signal, 108-110, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985577-60985577, hg38,18:63318344-63318344","hg19,18:g.60985577T>A, hg38,18:g.63318344T>A",0.300,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
290,108,Y,H,,,,,,,,,,S,"NRD cleavage site, 106-108, ELM|PCSK cleavage site, 107-111, ELM|di Arginine retention/retrieving signal, 106-108, ELM|di Arginine retention/retrieving signal, 108-110, ELM",,cBioPortal,"dlbc_broad_2012, dlbcl_dfci_2018, dlbcl_duke_2017","Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985578-60985578","hg19,18:g.60985578A>G",0.482,,,,
291,108,Y,S,,,,,,,,,,S,"NRD cleavage site, 106-108, ELM|PCSK cleavage site, 107-111, ELM|di Arginine retention/retrieving signal, 106-108, ELM|di Arginine retention/retrieving signal, 108-110, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985577-60985577, hg38,18:63318344-63318344","hg19,18:g.60985577T>G, hg38,18:g.63318344T>G",0.408,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
292,109,R,C,,,,,,,,,,S,"NRD cleavage site, 109-111, ELM|PCSK cleavage site, 107-111, ELM|di Arginine retention/retrieving signal, 108-110, ELM",,cBioPortal,"dlbcl_duke_2017, mds_iwg_2022","Diffuse Large B-Cell Lymphoma, NOS, Myelodysplastic Syndromes","hg19,18:60985575-60985575","hg19,18:g.60985575G>A",0.256,,,0.0000040468790469,
293,110,R,H,,,,,,,,,,C,"NRD cleavage site, 109-111, ELM|PCSK cleavage site, 107-111, ELM|di Arginine retention/retrieving signal, 108-110, ELM",,"cBioPortal,COSMIC","crc_apc_impact_2020, crc_msk_2017, mixed_impact_subset_2022, mixed_selpercatinib_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,18:60985571-60985571, hg38,18:63318338-63318338","hg19,18:g.60985571C>T, hg38,18:g.63318338C>T",0.112,"large_intestine, caecum","carcinoma, adenocarcinoma",,
294,111,D,A,,,,,,,,,,S,"NRD cleavage site, 109-111, ELM|PCSK cleavage site, 107-111, ELM|Atg8 protein family ligands, 111-119, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985568-60985568","hg19,18:g.60985568T>G",0.150,,,,
295,111,D,E,,,,,,,,,,S,"NRD cleavage site, 109-111, ELM|PCSK cleavage site, 107-111, ELM|Atg8 protein family ligands, 111-119, ELM",,COSMIC,,,"hg38,18:63318334-63318334","hg38,18:g.63318334G>C",0.122,"haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
296,111,D,N,,,,,,,,,,S,"NRD cleavage site, 109-111, ELM|PCSK cleavage site, 107-111, ELM|Atg8 protein family ligands, 111-119, ELM",,cBioPortal,"msk_met_2021, rectal_msk_2019","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,18:60985569-60985569","hg19,18:g.60985569C>T",0.232,,,,
297,112,F,C,,,,,,,,,,S,"Atg8 protein family ligands, 111-119, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985565-60985565","hg19,18:g.60985565A>C",0.705,,,,
298,112,F,L,,,,,,,,,,S,"Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985566-60985566, hg38,18:63318333-63318333","hg19,18:g.60985566A>G, hg38,18:g.63318333A>G",0.501,"haematopoietic_and_lymphoid_tissue, abdomen, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
299,112,F,V,,,,,,,,,,S,"Atg8 protein family ligands, 111-119, ELM",,COSMIC,,,"hg38,18:63318333-63318333","hg38,18:g.63318333A>C",0.577,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
300,113,A,D,,,,,,,,,,S,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC","dlbcl_dfci_2018, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985562-60985562, hg38,18:63318329-63318329","hg19,18:g.60985562G>T, hg38,18:g.63318329G>T",0.052,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,0.0001593371574251
301,113,A,G,,,,,,,,,,S,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, mbn_mdacc_2013, msk_impact_2017, pancan_pcawg_2020","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985562-60985562, hg38,18:63318329-63318329","hg19,18:g.60985562G>C, hg38,18:g.63318329G>C",0.055,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, mesentery","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
302,113,A,V,,,,,,,,,,S,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985562-60985562, hg38,18:63318329-63318329","hg19,18:g.60985562G>A, hg38,18:g.63318329G>A",0.063,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
303,114,E,D,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC","msk_met_2021, pan_origimed_2020, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,18:60985558-60985558, hg38,18:63318325-63318325","hg19,18:g.60985558C>A, hg38,18:g.63318325C>A, hg38,18:g.63318325C>G",0.096,"haematopoietic_and_lymphoid_tissue, stomach","carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
304,114,E,Q,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC",sclc_ucologne_2015,Small Cell Lung Cancer,"hg19,18:60985560-60985560, hg38,18:63318327-63318327","hg19,18:g.60985560C>G, hg38,18:g.63318327C>G",0.073,lung,"carcinoma, small_cell_carcinoma",,
305,115,M,I,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, mbn_mdacc_2013, msk_access_2021, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,18:60985555-60985555, hg38,18:63318322-63318322","hg19,18:g.60985555C>G, hg19,18:g.60985555C>T, hg38,18:g.63318322C>T",0.198,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,
306,115,M,L,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985557-60985557, hg38,18:63318324-63318324","hg19,18:g.60985557T>G, hg38,18:g.63318324T>A",0.173,"haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
307,115,M,V,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985557-60985557","hg19,18:g.60985557T>C",0.238,,,,
308,116,S,C,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985553-60985553","hg19,18:g.60985553G>C",0.341,,,,
309,116,S,F,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, msk_met_2021","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985553-60985553, hg38,18:63318320-63318320","hg19,18:g.60985553G>A, hg38,18:g.63318320G>A",0.401,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
310,116,S,T,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985554-60985554","hg19,18:g.60985554A>T",0.162,,,,
311,117,S,G,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985551-60985551, hg38,18:63318318-63318318","hg19,18:g.60985551T>C, hg38,18:g.63318318T>C",0.072,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
312,117,S,N,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,cBioPortal,"ccle_broad_2019, mbn_mdacc_2013","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985550-60985550","hg19,18:g.60985550C>T",0.062,,,,
313,117,S,R,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, cll_iuopa_2015, lymphoma_cellline_msk_2020, mbn_mdacc_2013","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985549-60985549, hg38,18:63318316-63318316","hg19,18:g.60985549G>C, hg19,18:g.60985549G>T, hg38,18:g.63318316G>C, hg38,18:g.63318316G>T",0.056,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, central_nervous_system","lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma",,
314,117,S,T,,,,,,,,,,C,"USP7 binding motif, 113-117, ELM|Atg8 protein family ligands, 111-119, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985550-60985550","hg19,18:g.60985550C>G",0.055,,,,
315,118,Q,H,,,,,,,,,,C,"Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985546-60985546, hg38,18:63318313-63318313","hg19,18:g.60985546C>G, hg38,18:g.63318313C>G",0.234,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, central_nervous_system","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma",,
316,118,Q,R,,,,,,,,,,C,"Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC",dlbcl_dfci_2018,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985547-60985547, hg38,18:63318314-63318314","hg19,18:g.60985547T>C, hg38,18:g.63318314T>C",0.260,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",0.0000039956207996,
317,119,L,M,,,,,,,,,,C,"WW domain ligands, 119-124, ELM|Atg8 protein family ligands, 111-119, ELM",,COSMIC,,,"hg38,18:63318312-63318312","hg38,18:g.63318312G>T",0.294,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000039924941111,
318,119,L,P,,,,,,,,,,C,"WW domain ligands, 119-124, ELM|Atg8 protein family ligands, 111-119, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,18:60985544-60985544","hg19,18:g.60985544A>G",0.659,,,,
319,119,L,V,,,,,,,,,,C,"WW domain ligands, 119-124, ELM|Atg8 protein family ligands, 111-119, ELM",,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018","Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985545-60985545, hg38,18:63318312-63318312","hg19,18:g.60985545G>C, hg38,18:g.63318312G>C",0.283,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
320,120,H,D,,,,,,,,,,C,"WW domain ligands, 119-124, ELM",,COSMIC,,,"hg38,18:63318309-63318309","hg38,18:g.63318309G>C",0.226,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
321,120,H,N,,,,,,,,,,C,"WW domain ligands, 119-124, ELM",,COSMIC,,,"hg38,18:63318309-63318309","hg38,18:g.63318309G>T",0.227,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
322,120,H,P,,,,,,,,,,C,"WW domain ligands, 119-124, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985541-60985541","hg19,18:g.60985541T>G",0.415,,,,
323,120,H,Y,,,,,,,,,,C,"WW domain ligands, 119-124, ELM",,"cBioPortal,COSMIC","dlbcl_dfci_2018, dlbcl_duke_2017, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985542-60985542, hg38,18:63318309-63318309","hg19,18:g.60985542G>A, hg38,18:g.63318309G>A",0.166,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
324,121,L,M,,,,,,,,,,S,"WW domain ligands, 119-124, ELM",,"cBioPortal,COSMIC",glioma_mskcc_2019,Diffuse Glioma,"hg19,18:60985539-60985539, hg38,18:63318306-63318306","hg19,18:g.60985539G>T, hg38,18:g.63318306G>T",0.153,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
325,121,L,V,,,,,,,,,,S,"WW domain ligands, 119-124, ELM",,COSMIC,,,"hg38,18:63318306-63318306","hg38,18:g.63318306G>C",0.089,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
326,122,T,M,,,,,,,,,,S,"WW domain ligands, 119-124, ELM",,COSMIC,,,"hg38,18:63318302-63318302","hg38,18:g.63318302G>A",0.220,stomach,"carcinoma, adenocarcinoma",,
327,123,P,,,,,,,,,,,S,"WW domain ligands, 119-124, ELM",,,,,,,,,,,
328,124,F,I,,,,,,,,,,S,"WW domain ligands, 119-124, ELM",,"cBioPortal,COSMIC",dlbcl_dfci_2018,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985530-60985530, hg38,18:63318297-63318297","hg19,18:g.60985530A>T, hg38,18:g.63318297A>T",0.036,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
329,124,F,L,,,,,,,,,,S,"WW domain ligands, 119-124, ELM",,"cBioPortal,COSMIC","cll_iuopa_2015, dlbcl_dfci_2018, dlbcl_duke_2017, mbn_mdacc_2013","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985528-60985528, hg19,18:60985530-60985530, hg38,18:63318295-63318295, hg38,18:63318297-63318297","hg19,18:g.60985528G>T, hg19,18:g.60985530A>G, hg38,18:g.63318295G>T, hg38,18:g.63318297A>G","0.019, 0.049",haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000398838582049,0.0002549719530852
330,124,F,S,,,,,,,,,,S,"WW domain ligands, 119-124, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985529-60985529, hg38,18:63318296-63318296","hg19,18:g.60985529A>G, hg38,18:g.63318296A>G",0.042,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
331,124,F,V,,,,,,,,,,S,"WW domain ligands, 119-124, ELM",,COSMIC,,,"hg38,18:63318297-63318297","hg38,18:g.63318297A>C",0.030,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
332,125,T,N,,,,,,,,,,S,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985526-60985526, hg38,18:63318293-63318293","hg19,18:g.60985526G>T, hg38,18:g.63318293G>T",0.244,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
333,125,T,S,,,,,,,,,,S,,,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018","Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985526-60985526, hg38,18:63318294-63318294","hg19,18:g.60985526G>C, hg38,18:g.63318294T>A","0.078, 0.110",haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
334,126,A,,,,,,,,,,,S,,,,,,,,,,,,
335,127,R,W,,,,,,,,,,S,"di Arginine retention/retrieving signal, 127-130, ELM",,cBioPortal,"luad_msk_npjpo_2021, luad_mskcc_2020, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,18:60985521-60985521","hg19,18:g.60985521G>A",0.160,,,,
336,128,G,E,,,,,,,,,,S,"di Arginine retention/retrieving signal, 127-130, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,18:60985517-60985517, hg38,18:63318284-63318284","hg19,18:g.60985517C>T, hg38,18:g.63318284C>T",0.067,stomach,"carcinoma, adenocarcinoma",,
337,128,G,R,,,,,,,,,,S,"di Arginine retention/retrieving signal, 127-130, ELM",,"cBioPortal,COSMIC","blca_bgi, dlbcl_duke_2017, mbn_mdacc_2013","Bladder Urothelial Carcinoma, Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985518-60985518, hg38,18:63318285-63318285","hg19,18:g.60985518C>T, hg38,18:g.63318285C>G, hg38,18:g.63318285C>T",0.094,"haematopoietic_and_lymphoid_tissue, urinary_tract, bladder","carcinoma, carcinoma, transitional_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000239215373575,
338,128,G,V,,,,,,,,,,S,"di Arginine retention/retrieving signal, 127-130, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985517-60985517, hg38,18:63318284-63318284","hg19,18:g.60985517C>A, hg38,18:g.63318284C>A",0.105,"haematopoietic_and_lymphoid_tissue, abdomen","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
339,129,R,C,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|di Arginine retention/retrieving signal, 127-130, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, coadread_dfci_2016, lymphoma_cellline_msk_2020, mbn_mdacc_2013, nhl_bcgsc_2013","Colorectal Adenocarcinoma, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985515-60985515, hg38,18:63318282-63318282","hg19,18:g.60985515G>A, hg38,18:g.63318282G>A",0.281,"haematopoietic_and_lymphoid_tissue, large_intestine","carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000279104632339,0.0000318735258494
340,129,R,H,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|di Arginine retention/retrieving signal, 127-130, ELM",,"cBioPortal,COSMIC","crc_msk_2017, dlbc_tcga, dlbc_tcga_pan_can_atlas_2018, dlbcl_dfci_2018, dlbcl_duke_2017, mbn_mdacc_2013, msk_impact_2017, msk_met_2021, rectal_msk_2019","Colorectal Adenocarcinoma, Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985514-60985514, hg38,18:63318281-63318281","hg19,18:g.60985514C>T, hg38,18:g.63318281C>T",0.325,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, large_intestine, rectum","carcinoma, adenocarcinoma, lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
341,129,R,L,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|di Arginine retention/retrieving signal, 127-130, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, pancan_pcawg_2020","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985514-60985514, hg38,18:63318281-63318281","hg19,18:g.60985514C>A, hg38,18:g.63318281C>A",0.273,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
342,129,R,S,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|di Arginine retention/retrieving signal, 127-130, ELM",,COSMIC,,,"hg38,18:63318282-63318282","hg38,18:g.63318282G>T",0.205,lung,"carcinoma, non_small_cell_carcinoma",0.0000119616271003,
343,129,R,Y,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|di Arginine retention/retrieving signal, 127-130, ELM",,COSMIC,,,"hg38,18:63318281-63318282","hg38,18:g.63318281_63318282delinsTA",,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
344,130,F,,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM|di Arginine retention/retrieving signal, 127-130, ELM",,,,,,,,,,,
345,131,A,D,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC","gbm_tcga_pan_can_atlas_2018, lymphoma_cellline_msk_2020, mbn_mdacc_2013, msk_impact_2017, pancan_pcawg_2020","Glioblastoma Multiforme, Lymphoid, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985508-60985508, hg38,18:63318275-63318275","hg19,18:g.60985508G>T, hg38,18:g.63318275G>T",0.224,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, mesentery, haematopoietic_and_lymphoid_tissue, retroperitoneum","lymphoid_neoplasm, lymphoid_neoplasm, B_cell_lymphoma_unspecified, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
346,131,A,G,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, pancan_pcawg_2020","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985508-60985508, hg38,18:63318275-63318275","hg19,18:g.60985508G>C, hg38,18:g.63318275G>C",0.112,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
347,131,A,T,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, dlbcl_duke_2017, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985509-60985509, hg38,18:63318276-63318276","hg19,18:g.60985509C>T, hg38,18:g.63318276C>T",0.135,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
348,131,A,V,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cscc_dfarber_2015, dlbcl_dfci_2018, dlbcl_duke_2017, mbn_mdacc_2013, msk_impact_2017, nhl_bcgsc_2013, pancan_pcawg_2020","Cutaneous Squamous Cell Carcinoma, Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types, Non-Hodgkin Lymphoma","hg19,18:60985508-60985508, hg38,18:63318275-63318275","hg19,18:g.60985508G>A, hg38,18:g.63318275G>A",0.121,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, mediastinum, skin","carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",,
349,132,T,A,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985506-60985506, hg38,18:63318273-63318273","hg19,18:g.60985506T>C, hg38,18:g.63318273T>C",0.045,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
350,132,T,M,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985505-60985505, hg38,18:63318272-63318272","hg19,18:g.60985505G>A, hg38,18:g.63318272G>A",0.140,"haematopoietic_and_lymphoid_tissue, retroperitoneum","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
351,132,T,S,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,COSMIC,,,"hg38,18:63318273-63318273","hg38,18:g.63318273T>A",0.059,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
352,133,V,A,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985502-60985502, hg38,18:63318269-63318269","hg19,18:g.60985502A>G, hg38,18:g.63318269A>G",0.600,"haematopoietic_and_lymphoid_tissue, mesentery","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
353,133,V,E,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,COSMIC,,,"hg38,18:63318269-63318269","hg38,18:g.63318269A>T",0.754,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
354,133,V,L,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985503-60985503","hg19,18:g.60985503C>G",0.406,,,,
355,133,V,M,,,,,,,,,,S,"PCSK cleavage site, 129-133, ELM|14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985503-60985503, hg38,18:63318270-63318270","hg19,18:g.60985503C>T, hg38,18:g.63318270C>T",0.435,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
356,134,V,A,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985499-60985499, hg38,18:63318266-63318266","hg19,18:g.60985499A>G, hg38,18:g.63318266A>G",0.195,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node, skin, lower_leg","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, malignant_melanoma",,
357,134,V,L,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985500-60985500, hg38,18:63318267-63318267","hg19,18:g.60985500C>G, hg38,18:g.63318267C>A, hg38,18:g.63318267C>G",0.143,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, retroperitoneum","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
358,134,V,M,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 129-134, ELM|FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985500-60985500, hg38,18:63318267-63318267","hg19,18:g.60985500C>T, hg38,18:g.63318267C>T",0.162,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
359,135,E,D,,,,,,,,,,S,"FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985495-60985495, hg38,18:63318262-63318262","hg19,18:g.60985495C>G, hg38,18:g.63318262C>G",0.069,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
360,135,E,G,,,,,,,,,,S,"FHA phosphopeptide ligands, 130-136, ELM",,COSMIC,,,"hg38,18:63318263-63318263","hg38,18:g.63318263T>C",0.233,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
361,136,E,D,,,,,,,,,,S,"FHA phosphopeptide ligands, 130-136, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985492-60985492, hg38,18:63318259-63318259","hg19,18:g.60985492C>G, hg38,18:g.63318259C>G",0.320,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, primary_central_nervous_system_B_cell_lymphoma",,
362,136,E,G,,,,,,,,,,S,"FHA phosphopeptide ligands, 130-136, ELM",,COSMIC,,,"hg38,18:63318260-63318260","hg38,18:g.63318260T>C",0.642,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
363,137,L,F,,,,,,,,,,S,,,cBioPortal,pcnsl_mayo_2015,Primary DLBCL of the central nervous system,"hg19,18:60985491-60985491","hg19,18:g.60985491G>A",0.493,,,,
364,138,F,,,,,,,,,,,S,,,,,,,,,,,,
365,139,R,S,,,,,,,,,,S,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,18:60985483-60985483, hg38,18:63318250-63318250","hg19,18:g.60985483C>A, hg38,18:g.63318250C>A",0.241,skin,malignant_melanoma,,
366,140,D,N,,,,,,,,,,S,,,cBioPortal,"mixed_allen_2018, skcm_mskcc_2014","Cutaneous Melanoma, Mixed Cancer Types","hg19,18:60985482-60985482","hg19,18:g.60985482C>T",0.395,,,,
367,141,G,R,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318246-63318246","hg38,18:g.63318246C>T",0.490,stomach,"carcinoma, adenocarcinoma",,
368,141,G,V,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318245-63318245","hg38,18:g.63318245C>A",0.497,,malignant_melanoma,,
369,142,V,,,,,,,,,,,S,,,,,,,,,,,,
370,143,N,K,,,,,,,,,,S,,,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021, prad_pik3r1_msk_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,18:60985471-60985471","hg19,18:g.60985471G>T",0.433,,,,
371,143,N,S,,,,,,,,,,S,,,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985472-60985472, hg38,18:63318239-63318239","hg19,18:g.60985472T>C, hg38,18:g.63318239T>C",0.454,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
372,143,N,T,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318239-63318239","hg38,18:g.63318239T>G",0.471,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
373,144,W,,,,,,,,,,,S,"PP1-docking motif RVXF, 144-151, ELM",,,,,,,,,,,
374,145,G,E,,,,,,,,,,S,"PP1-docking motif RVXF, 144-151, ELM",,"cBioPortal,COSMIC","lung_msk_2017, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,18:60985466-60985466, hg38,18:63318233-63318233","hg19,18:g.60985466C>T, hg38,18:g.63318233C>T",0.766,lung,"carcinoma, adenocarcinoma",,
375,145,G,R,,,,,,,,,,S,"PP1-docking motif RVXF, 144-151, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,18:60985467-60985467","hg19,18:g.60985467C>T",0.764,,,,
376,146,R,K,,,,,,,,,,S,"PP1-docking motif RVXF, 144-151, ELM",,COSMIC,,,"hg38,18:63318230-63318230","hg38,18:g.63318230C>T",0.501,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, primary_central_nervous_system_B_cell_lymphoma",,
377,147,I,L,,,,,,,,,,S,"PP1-docking motif RVXF, 144-151, ELM",,COSMIC,,,"hg38,18:63318228-63318228","hg38,18:g.63318228T>G",0.301,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
378,148,V,,,,,,,,,,,S,"PP1-docking motif RVXF, 144-151, ELM",,,,,,,,,,,
379,149,A,,,,,,,,,,,S,"PP1-docking motif RVXF, 144-151, ELM",,,,,,,,,,,
380,150,F,L,,,,,,,,,,S,"PP1-docking motif RVXF, 144-151, ELM",,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985450-60985450","hg19,18:g.60985450G>C",0.319,,,,
381,151,F,,,,,,,,,,,S,"PP1-docking motif RVXF, 144-151, ELM",,,,,,,,,,,
382,152,E,G,,,,,,,,,,S,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985444-60985445","hg19,18:g.60985444_60985445delinsTC",,,,,
383,153,F,L,,,,,,,,,,S,,,cBioPortal,"mbn_mdacc_2013, msk_met_2021","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985441-60985441, hg19,18:60985443-60985443","hg19,18:g.60985441G>T, hg19,18:g.60985443A>G","0.435, 0.728",,,,
384,153,F,S,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318209-63318209","hg38,18:g.63318209A>G",0.769,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
385,154,G,D,,,,,,,,,,S,,,cBioPortal,"hcc_meric_2021, msk_met_2021","Hepatocellular Carcinoma, Mixed Cancer Types","hg19,18:60985439-60985439","hg19,18:g.60985439C>T",0.664,,,,
386,154,G,S,,,,,,,,,,S,,,cBioPortal,blca_msk_tcga_2020,Bladder Urothelial Carcinoma,"hg19,18:60985440-60985440","hg19,18:g.60985440C>T",0.588,,,,
387,155,G,A,,,,,,,,,,S,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,18:60985435-60985436, hg38,18:63318203-63318203","hg19,18:g.60985435_60985436delinsTG, hg38,18:g.63318203C>G",0.345,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
388,155,G,V,,,,,,,,,,S,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,18:60985436-60985436, hg38,18:63318203-63318203","hg19,18:g.60985436C>A, hg38,18:g.63318203C>A",0.408,skin,malignant_melanoma,,
389,156,V,A,,,,,,,,,,S,,,"cBioPortal,COSMIC",pog570_bcgsc_2020,Mixed Cancer Types,"hg19,18:60985433-60985433, hg38,18:63318200-63318200","hg19,18:g.60985433A>G, hg38,18:g.63318200A>G",0.182,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
390,156,V,F,,,,,,,,,,S,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,18:60985434-60985434","hg19,18:g.60985434C>A",0.158,,,0.0000198898895713,
391,156,V,G,,,,,,,,,,S,,,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985433-60985433","hg19,18:g.60985433A>C",0.273,,,,
392,156,V,I,,,,,,,,,,S,,,"cBioPortal,COSMIC","dlbcl_duke_2017, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985434-60985434, hg38,18:63318201-63318201","hg19,18:g.60985434C>T, hg38,18:g.63318201C>T",0.051,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
393,156,V,L,,,,,,,,,,S,,,"cBioPortal,COSMIC","mbn_mdacc_2013, pancan_pcawg_2020","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985434-60985434, hg38,18:63318201-63318201","hg19,18:g.60985434C>G, hg38,18:g.63318201C>G",0.064,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, follicular_lymphoma",,
394,157,M,L,,,,,,,,,,S,,,cBioPortal,"dlbc_broad_2012, dlbcl_dfci_2018, mbn_mdacc_2013, pancan_pcawg_2020","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985431-60985431","hg19,18:g.60985431T>A, hg19,18:g.60985431T>G",0.109,,,,
395,158,C,,,,,,,,,,,S,,,,,,,,,,,,
396,159,V,A,,,,,,,,,,S,,,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985424-60985424, hg38,18:63318191-63318191","hg19,18:g.60985424A>G, hg38,18:g.63318191A>G",0.110,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
397,159,V,M,,,,,,,,,,S,,,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985425-60985425","hg19,18:g.60985425C>T",0.292,,,,
398,160,E,D,,,,,,,,,,S,,,"cBioPortal,COSMIC","egc_tmucih_2015, pan_origimed_2020","Esophagogastric Adenocarcinoma, Mixed Cancer Types","hg19,18:60985420-60985420, hg38,18:63318187-63318187","hg19,18:g.60985420C>A, hg38,18:g.63318187C>G","0.293, 0.294","urinary_tract, bladder","carcinoma, small_cell_carcinoma",,
399,160,E,K,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60985422-60985423","hg19,18:g.60985422_60985423delinsTT",,,,,
400,160,E,Q,,,,,,,,,,S,,,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985422-60985422","hg19,18:g.60985422C>G",0.336,,,,
401,161,S,N,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318185-63318185","hg38,18:g.63318185C>T",0.241,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
402,161,S,T,,,,,,,,,,S,,,cBioPortal,"dlbcl_dfci_2018, mbn_mdacc_2013","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms","hg19,18:60985418-60985418","hg19,18:g.60985418C>G",0.137,,,,
403,162,V,,,,,,,,,,,S,,,,,,,,,,,,
404,163,N,D,,,,,,,,,,S,,,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985413-60985413, hg38,18:63318180-63318180","hg19,18:g.60985413T>C, hg38,18:g.63318180T>C",0.102,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, tonsil","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",,
405,163,N,K,,,,,,,,,,S,,,"cBioPortal,COSMIC","dlbcl_dfci_2018, pancan_pcawg_2020","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985411-60985411, hg38,18:63318178-63318178","hg19,18:g.60985411G>C, hg38,18:g.63318178G>C",0.133,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
406,163,N,S,,,,,,,,,,S,,,"cBioPortal,COSMIC","dlbc_broad_2012, dlbcl_dfci_2018, dlbcl_duke_2017","Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985412-60985412, hg38,18:63318179-63318179","hg19,18:g.60985412T>C, hg38,18:g.63318179T>C",0.113,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
407,163,N,T,,,,,,,,,,S,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985412-60985412, hg38,18:63318179-63318179","hg19,18:g.60985412T>G, hg38,18:g.63318179T>G",0.159,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
408,164,R,Q,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,COSMIC,,,"hg38,18:63318176-63318176","hg38,18:g.63318176C>T",0.174,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, follicular_lymphoma",,
409,165,E,D,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985405-60985405, hg38,18:63318172-63318172","hg19,18:g.60985405C>G, hg38,18:g.63318172C>G",0.174,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
410,165,E,G,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985406-60985406, hg38,18:63318173-63318173","hg19,18:g.60985406T>C, hg38,18:g.63318173T>C",0.261,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
411,165,E,K,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, mbn_mdacc_2013, msk_met_2021","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985407-60985407, hg38,18:63318174-63318174","hg19,18:g.60985407C>T, hg38,18:g.63318174C>T",0.349,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
412,166,M,,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,,,,,,,,,,
413,167,S,A,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985401-60985401, hg38,18:63318168-63318168","hg19,18:g.60985401A>C, hg38,18:g.63318168A>C",0.039,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",,
414,167,S,L,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,cBioPortal,"msk_met_2021, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,18:60985400-60985400","hg19,18:g.60985400G>A",0.125,,,,
415,167,S,P,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,COSMIC,,,"hg38,18:63318168-63318168","hg38,18:g.63318168A>G",0.155,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
416,167,S,T,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,COSMIC,,,"hg38,18:63318168-63318168","hg38,18:g.63318168A>T",0.025,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
417,168,P,R,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,"cBioPortal,COSMIC",skcm_yale,Cutaneous Melanoma,"hg19,18:60985397-60985397, hg38,18:63318164-63318164","hg19,18:g.60985397G>C, hg38,18:g.63318164G>C",0.167,skin,malignant_melanoma,,
418,168,P,S,,,,,,,,,,S,"WW domain ligands, 164-169, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985398-60985398","hg19,18:g.60985398G>A",0.084,,,0.0000039775665248,
419,169,L,M,,,,,,,,,,S,"WW domain ligands, 164-169, ELM|GTPase-binding domain (GBD) ligand, 169-177, ELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,18:60985395-60985395, hg38,18:63318162-63318162","hg19,18:g.60985395G>T, hg38,18:g.63318162G>T",0.266,"haematopoietic_and_lymphoid_tissue, liver","carcinoma, hepatocellular_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
420,169,L,Q,,,,,,,,,,S,"WW domain ligands, 164-169, ELM|GTPase-binding domain (GBD) ligand, 169-177, ELM",,COSMIC,,,"hg38,18:63318161-63318161","hg38,18:g.63318161A>T",0.284,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
421,170,V,E,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,COSMIC,,,"hg38,18:63318158-63318158","hg38,18:g.63318158A>T",0.705,lung,"carcinoma, non_small_cell_carcinoma",,
422,170,V,M,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,COSMIC,,,"hg38,18:63318159-63318159","hg38,18:g.63318159C>T",0.445,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
423,171,D,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,,,,,,,,,,
424,172,N,D,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,cBioPortal,dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985386-60985386","hg19,18:g.60985386T>C",0.088,,,,
425,172,N,K,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,18:60985384-60985384, hg38,18:63318151-63318151","hg19,18:g.60985384G>T, hg38,18:g.63318151G>T",0.114,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
426,172,N,Q,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985384-60985386, hg38,18:63318151-63318153","hg19,18:g.60985384_60985386delinsCTG, hg38,18:g.63318151_63318153delinsCTG",,"haematopoietic_and_lymphoid_tissue, soft_tissue","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
427,172,N,S,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,"cBioPortal,COSMIC","crc_msk_2017, dlbc_broad_2012, dlbcl_dfci_2018, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types","hg19,18:60985385-60985385, hg38,18:63318152-63318152","hg19,18:g.60985385T>C, hg38,18:g.63318152T>C",0.017,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, central_nervous_system, large_intestine, colon, ascending","carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, primary_central_nervous_system_lymphoma",0.0000039778513238,
428,173,I,F,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,COSMIC,,,"hg38,18:63318150-63318150","hg38,18:g.63318150T>A",0.555,"haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, primary_bone_diffuse_large_B_cell_lymphoma",,
429,173,I,V,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,"cBioPortal,COSMIC","dlbcl_duke_2017, mbn_mdacc_2013, msk_impact_2017","Diffuse Large B-Cell Lymphoma, NOS, Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985383-60985383, hg38,18:63318150-63318150","hg19,18:g.60985383T>C, hg38,18:g.63318150T>C",0.299,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
430,174,A,T,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985380-60985380, hg38,18:63318147-63318147","hg19,18:g.60985380C>T, hg38,18:g.63318147C>T",0.278,"skin, stomach","adenoma, carcinoma, squamous_cell_carcinoma",0.0000039777247414,
431,174,A,V,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985379-60985379, hg38,18:63318146-63318146","hg19,18:g.60985379G>A, hg38,18:g.63318146G>A",0.197,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, follicular_lymphoma",,
432,175,L,V,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 169-177, ELM",,"cBioPortal,COSMIC","mbn_mdacc_2013, pancan_pcawg_2020","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985377-60985377, hg38,18:63318144-63318144","hg19,18:g.60985377G>C, hg38,18:g.63318144G>C",0.019,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
433,176,W,,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|GTPase-binding domain (GBD) ligand, 169-177, ELM|Pex14 ligand motif, 176-180, ELM",,,,,,,,,,,
434,177,M,,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|GTPase-binding domain (GBD) ligand, 169-177, ELM|Pex14 ligand motif, 176-180, ELM",,,,,,,,,,,
435,178,T,N,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|Pex14 ligand motif, 176-180, ELM",,cBioPortal,cesc_tcga_pan_can_atlas_2018,Cervical Squamous Cell Carcinoma,"hg19,18:60985367-60985367","hg19,18:g.60985367G>T",0.319,,,,
436,179,E,D,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|Pex14 ligand motif, 176-180, ELM",,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985363-60985363, hg38,18:63318130-63318130","hg19,18:g.60985363C>G, hg38,18:g.63318130C>G",0.064,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone, haematopoietic_and_lymphoid_tissue, lymph_node, haematopoietic_and_lymphoid_tissue, spleen","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma, lymphoid_neoplasm, marginal_zone_lymphoma",,
437,180,Y,D,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|Pex14 ligand motif, 176-180, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM",,cBioPortal,"dlbc_broad_2012, dlbcl_dfci_2018","Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985362-60985362","hg19,18:g.60985362A>C",0.722,,,,
438,180,Y,F,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|Pex14 ligand motif, 176-180, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM",,cBioPortal,"dlbc_broad_2012, dlbcl_dfci_2018, dlbcl_duke_2017","Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985361-60985361","hg19,18:g.60985361T>A",0.437,,,,
439,180,Y,H,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|Pex14 ligand motif, 176-180, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM",,COSMIC,,,"hg38,18:63318129-63318129","hg38,18:g.63318129A>G",0.681,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
440,181,L,M,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM",,COSMIC,,,"hg38,18:63318126-63318126","hg38,18:g.63318126G>T",0.374,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
441,181,L,P,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,18:60985358-60985358, hg38,18:63318125-63318125","hg19,18:g.60985358A>G, hg38,18:g.63318125A>G",0.754,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
442,181,L,V,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM",,COSMIC,,,"hg38,18:63318126-63318126","hg38,18:g.63318126G>C",0.362,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000039783577339,
443,182,N,D,,,,,,,,,,S,"FHA phosphopeptide ligands, 176-182, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985356-60985356, hg38,18:63318123-63318123","hg19,18:g.60985356T>C, hg38,18:g.63318123T>C",0.159,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, bone","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
444,183,R,P,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,18:60985352-60985352","hg19,18:g.60985352C>G",0.176,,,,
445,183,R,Q,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM|Phosphotyrosine ligands bound by SH2 domains, 180-183, ELM",,COSMIC,,,"hg38,18:63318119-63318119","hg38,18:g.63318119C>T",0.078,stomach,carcinoma,,
446,184,H,D,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,COSMIC,,,"hg38,18:63318117-63318117","hg38,18:g.63318117G>C",0.150,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
447,184,H,N,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985350-60985350, hg38,18:63318117-63318117","hg19,18:g.60985350G>T, hg38,18:g.63318117G>T",0.133,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, follicular_lymphoma",,
448,184,H,Y,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,COSMIC,,,"hg38,18:63318117-63318117","hg38,18:g.63318117G>A",0.125,"haematopoietic_and_lymphoid_tissue, mediastinum","lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",,
449,185,L,M,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60985347-60985347","hg19,18:g.60985347G>T",0.302,,,,
450,186,H,D,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985344-60985344, hg38,18:63318111-63318111","hg19,18:g.60985344G>C, hg38,18:g.63318111G>C",0.118,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, malignant_histiocytosis",,
451,186,H,Q,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,COSMIC,,,"hg38,18:63318109-63318109","hg38,18:g.63318109G>T",0.046,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
452,186,H,Y,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,"cBioPortal,COSMIC",dlbcl_duke_2017,"Diffuse Large B-Cell Lymphoma, NOS","hg19,18:60985344-60985344, hg38,18:63318111-63318111","hg19,18:g.60985344G>A, hg38,18:g.63318111G>A",0.134,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
453,187,T,A,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,COSMIC,,,"hg38,18:63318108-63318108","hg38,18:g.63318108T>C",0.058,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
454,187,T,I,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,"cBioPortal,COSMIC",nhl_bcgsc_2013,Non-Hodgkin Lymphoma,"hg19,18:60985340-60985340, hg38,18:63318107-63318107","hg19,18:g.60985340G>A, hg38,18:g.63318107G>A",0.075,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
455,188,W,L,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,COSMIC,,,"hg38,18:63318104-63318104","hg38,18:g.63318104C>A",0.623,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
456,189,I,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 183-189, ELM",,,,,,,,,,,
457,190,Q,E,,,,,,,,,,S,,,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985332-60985332","hg19,18:g.60985332G>C",0.137,,,,
458,190,Q,H,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318097-63318097","hg38,18:g.63318097C>G",0.183,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
459,190,Q,R,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318098-63318098","hg38,18:g.63318098T>C",0.074,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
460,191,D,E,,,,,,,,,,S,,,"cBioPortal,COSMIC",mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60985327-60985327, hg38,18:63318094-63318094","hg19,18:g.60985327A>C, hg19,18:g.60985327A>T, hg38,18:g.63318094A>T",0.032,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
461,191,D,N,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318096-63318096","hg38,18:g.63318096C>T",0.216,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
462,192,N,H,,,,,,,,,,S,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60985326-60985326, hg38,18:63318093-63318093","hg19,18:g.60985326T>G, hg38,18:g.63318093T>G",0.277,"haematopoietic_and_lymphoid_tissue, large_intestine","lymphoid_neoplasm, follicular_lymphoma",,
463,193,G,E,,,,,,,,,,S,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,18:60985322-60985322","hg19,18:g.60985322C>T",0.638,,,,
464,194,G,D,,,,,,,,,,S,,,"cBioPortal,COSMIC","mbn_mdacc_2013, msk_impact_2017","Mature B-Cell Neoplasms, Mixed Cancer Types","hg19,18:60985319-60985319, hg38,18:63318086-63318086","hg19,18:g.60985319C>T, hg38,18:g.63318086C>T",0.644,"haematopoietic_and_lymphoid_tissue, haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, lymphoid_neoplasm, follicular_lymphoma",,
465,195,W,L,,,,,,,,,,S,,,COSMIC,,,"hg38,18:63318083-63318083","hg38,18:g.63318083C>A",0.635,large_intestine,"carcinoma, adenocarcinoma",,
466,196,D,Y,,,,,,,,,,S,"Atg8 protein family ligands, 196-206, ELM",,cBioPortal,prad_pik3r1_msk_2021,Prostate Adenocarcinoma,"hg19,18:60795992-60795992","hg19,18:g.60795992C>A",0.252,,,,
467,197,A,G,,,,,,,,,,S,"Atg8 protein family ligands, 196-206, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60795988-60795988","hg19,18:g.60795988G>C",0.147,,,0.0000040075984066,
468,197,A,S,,,,,,,,,,S,"Atg8 protein family ligands, 196-206, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60795989-60795989","hg19,18:g.60795989C>A",0.107,,,,
469,197,A,T,,,,,,,,,,S,"Atg8 protein family ligands, 196-206, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,18:60795989-60795989, hg38,18:63128756-63128756","hg19,18:g.60795989C>T, hg38,18:g.63128756C>T",0.150,lung,"carcinoma, adenocarcinoma",0.0000040065707761,
470,198,F,,,,,,,,,,,S,"Atg8 protein family ligands, 196-206, ELM",,,,,,,,,,,
471,199,V,,,,,,,,,,,S,"Atg8 protein family ligands, 196-206, ELM",,,,,,,,,,,
472,200,E,D,,,,,,,,,,S,"Atg8 protein family ligands, 196-206, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,18:60795978-60795978","hg19,18:g.60795978T>A",0.125,,,,
473,201,L,R,,,,,,,,,,S,"Atg8 protein family ligands, 196-206, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60795976-60795976","hg19,18:g.60795976A>C",0.412,,,,
474,202,Y,F,,,,,,,,,,S,"Atg8 protein family ligands, 196-206, ELM",,cBioPortal,mbn_mdacc_2013,Mature B-Cell Neoplasms,"hg19,18:60795973-60795973","hg19,18:g.60795973T>A",0.110,,,,
475,203,G,S,,,,,,,,,,C,"Atg8 protein family ligands, 196-206, ELM",,COSMIC,,,"hg38,18:63128738-63128738","hg38,18:g.63128738C>T",0.076,"haematopoietic_and_lymphoid_tissue, large_intestine","carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0001955073215497,0.0001911436763300
476,204,P,H,,,,,,,,,,C,"Atg8 protein family ligands, 196-206, ELM|Rb pocket AB groove ligand, 204-212, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60795967-60795967","hg19,18:g.60795967G>T",0.039,,,,
477,205,S,N,,,,,,,,,,C,"Atg8 protein family ligands, 196-206, ELM|Rb pocket AB groove ligand, 204-212, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,18:60795964-60795964","hg19,18:g.60795964C>T",0.042,,,,
478,205,S,R,,,,,,,,,,C,"Atg8 protein family ligands, 196-206, ELM|Rb pocket AB groove ligand, 204-212, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60795965-60795965","hg19,18:g.60795965T>G",0.046,,,,
479,206,M,,,,,,,,,,,C,"Atg8 protein family ligands, 196-206, ELM|Rb pocket AB groove ligand, 204-212, ELM",,,,,,,,,,,
480,207,R,Q,,,,,,,,,,C,"PCSK cleavage site, 207-211, ELM|Rb pocket AB groove ligand, 204-212, ELM",,cBioPortal,"dlbcl_duke_2017, msk_met_2021, sarcoma_mskcc_2022","Diffuse Large B-Cell Lymphoma, NOS, Mixed Cancer Types, Soft Tissue","hg19,18:60795958-60795958","hg19,18:g.60795958C>T",0.071,,,0.0000119526674369,
481,207,R,W,,,,,,,,,,C,"PCSK cleavage site, 207-211, ELM|Rb pocket AB groove ligand, 204-212, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, coadread_tcga_pan_can_atlas_2018, msk_met_2021, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,18:60795959-60795959, hg38,18:63128726-63128726","hg19,18:g.60795959G>A, hg38,18:g.63128726G>A",0.194,"endometrium, large_intestine, caecum, large_intestine, colon, descending, oesophagus, ovary","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, serous_carcinoma, carcinoma, squamous_cell_carcinoma",0.0000318989441449,0.0000636861546300
482,208,P,S,,,,,,,,,,s,"PCSK cleavage site, 207-211, ELM|Rb pocket AB groove ligand, 204-212, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,18:60795956-60795956, hg38,18:63128723-63128723","hg19,18:g.60795956G>A, hg38,18:g.63128723G>A",0.285,endometrium,"carcinoma, endometrioid_carcinoma",,
483,209,L,,,,,,,,,,,s,"PCSK cleavage site, 207-211, ELM|Rb pocket AB groove ligand, 204-212, ELM",,,,,,,,,,,
484,210,F,C,,,,,,,,,,s,"PCSK cleavage site, 207-211, ELM|MDM2 binding motif, 210-217, ELM|Pex14 ligand motif, 210-214, ELM|Rb pocket AB groove ligand, 204-212, ELM",,COSMIC,,,"hg38,18:63128716-63128716","hg38,18:g.63128716A>C",0.182,kidney,"carcinoma, chromophobe_renal_cell_carcinoma",,
485,211,D,,,,,,,,,,,s,"PCSK cleavage site, 207-211, ELM|MDM2 binding motif, 210-217, ELM|Atg8 protein family ligands, 211-221, ELM|Pex14 ligand motif, 210-214, ELM|Rb pocket AB groove ligand, 204-212, ELM",,,,,,,,,,,
486,212,F,L,,,,,,,,,,s,"MDM2 binding motif, 210-217, ELM|Atg8 protein family ligands, 211-221, ELM|Pex14 ligand motif, 210-214, ELM|Rb pocket AB groove ligand, 204-212, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,18:60795942-60795942, hg38,18:63128709-63128709","hg19,18:g.60795942G>T, hg38,18:g.63128709G>T",0.051,"large_intestine, colon, ascending, ovary","carcinoma, adenocarcinoma, carcinoma, mucinous_carcinoma",,
487,212,F,S,,,,,,,,,,s,"MDM2 binding motif, 210-217, ELM|Atg8 protein family ligands, 211-221, ELM|Pex14 ligand motif, 210-214, ELM|Rb pocket AB groove ligand, 204-212, ELM",,cBioPortal,"mixed_allen_2018, skcm_mskcc_2014","Cutaneous Melanoma, Mixed Cancer Types","hg19,18:60795943-60795943","hg19,18:g.60795943A>G",0.114,,,,
488,213,S,A,,,,,,,,,,s,"MDM2 binding motif, 210-217, ELM|Atg8 protein family ligands, 211-221, ELM|Pex14 ligand motif, 210-214, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60795941-60795941, hg38,18:63128708-63128708","hg19,18:g.60795941A>C, hg38,18:g.63128708A>C",0.117,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
489,213,S,F,,,,,,,,,,s,"MDM2 binding motif, 210-217, ELM|Atg8 protein family ligands, 211-221, ELM|Pex14 ligand motif, 210-214, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, pan_origimed_2020, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,18:60795940-60795940, hg38,18:63128707-63128707","hg19,18:g.60795940G>A, hg38,18:g.63128707G>A",0.186,skin,malignant_melanoma,,
490,214,W,C,,,,,,,,,,s,"MDM2 binding motif, 210-217, ELM|Atg8 protein family ligands, 211-221, ELM|Pex14 ligand motif, 210-214, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,18:60795936-60795936, hg38,18:63128703-63128703","hg19,18:g.60795936C>A, hg38,18:g.63128703C>A",0.318,lung,"carcinoma, adenocarcinoma",,
491,214,W,S,,,,,,,,,,s,"MDM2 binding motif, 210-217, ELM|Atg8 protein family ligands, 211-221, ELM|Pex14 ligand motif, 210-214, ELM",,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,18:60795937-60795937","hg19,18:g.60795937C>G",0.270,,,,
492,215,L,,,,,,,,,,,s,"MDM2 binding motif, 210-217, ELM|Atg8 protein family ligands, 211-221, ELM",,,,,,,,,,,
493,216,S,,,,,,,,,,,s,"MDM2 binding motif, 210-217, ELM|Atg8 protein family ligands, 211-221, ELM",,,,,,,,,,,
494,217,L,,,,,,,,,,,s,"MDM2 binding motif, 210-217, ELM|Atg8 protein family ligands, 211-221, ELM",,,,,,,,,,,
495,218,K,,,,,,,,,,,s,"Atg8 protein family ligands, 211-221, ELM",,,,,,,,,,,
496,219,T,I,,,,,,,,,,s,"Atg8 protein family ligands, 211-221, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60795922-60795922","hg19,18:g.60795922G>A",0.132,,,,
497,220,L,,,,,,,,,,,s,"Atg8 protein family ligands, 211-221, ELM",,,,,,,,,,,
498,221,L,,,,,,,,,,,s,"Atg8 protein family ligands, 211-221, ELM",,,,,,,,,,,
499,222,S,C,,,,,,,,,,s,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,18:60795914-60795914","hg19,18:g.60795914T>A",0.201,,,,
500,223,L,,,,,,,,,,,s,,,,,,,,,,,,
501,224,A,D,,,,,,,,,,s,,,COSMIC,,,"hg38,18:63128674-63128674","hg38,18:g.63128674G>T",0.314,liver,"other, neoplasm",,
502,224,A,S,,,,,,,,,,s,,,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,18:60795908-60795908, hg38,18:63128675-63128675","hg19,18:g.60795908C>A, hg38,18:g.63128675C>A",0.126,lung,"carcinoma, adenocarcinoma",,
503,224,A,T,,,,,,,,,,s,,,cBioPortal,ucs_jhu_2014,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,"hg19,18:60795908-60795908","hg19,18:g.60795908C>T",0.096,,,,
504,224,A,V,,,,,,,,,,s,,,"cBioPortal,COSMIC","pancan_pcawg_2020, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,18:60795907-60795907, hg38,18:63128674-63128674","hg19,18:g.60795907G>A, hg38,18:g.63128674G>A",0.013,skin,malignant_melanoma,,
505,225,L,,,,,,,,,,,s,,,,,,,,,,,,
506,226,V,M,,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,18:60795902-60795902","hg19,18:g.60795902C>T",0.110,,,,0.0000318369945877
507,227,G,V,,,,,,,,,,s,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,18:60795898-60795898, hg38,18:63128665-63128665","hg19,18:g.60795898C>A, hg38,18:g.63128665C>A",0.300,skin,malignant_melanoma,,
508,228,A,,,,,,,,,,,s,,,,,,,,,,,,
509,229,C,,,,,,,,,,,s,,,,,,,,,,,,
510,230,I,V,,,,,,,,,,s,,,"cBioPortal,COSMIC","lung_msk_2017, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,18:60795890-60795890, hg38,18:63128657-63128657","hg19,18:g.60795890T>C, hg38,18:g.63128657T>C",0.084,lung,"carcinoma, adenocarcinoma",0.0000039795293013,
511,231,T,I,,,,,,,,,,s,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018",Cutaneous Melanoma,"hg19,18:60795886-60795886, hg38,18:63128653-63128653","hg19,18:g.60795886G>A, hg38,18:g.63128653G>A",0.205,skin,malignant_melanoma,,
512,232,L,,,,,,,,,,,s,,,,,,,,,,,,
513,233,G,S,,,,,,,,,,s,,,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, msk_met_2021","Head and Neck Squamous Cell Carcinoma, Mixed Cancer Types","hg19,18:60795881-60795881, hg38,18:63128648-63128648","hg19,18:g.60795881C>T, hg38,18:g.63128648C>T",0.331,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
514,234,A,D,,,,,,,,,,s,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,18:60795877-60795877, hg38,18:63128644-63128644","hg19,18:g.60795877G>T, hg38,18:g.63128644G>T",0.368,ovary,"carcinoma, mixed_carcinoma",,
515,235,Y,,P,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 235-238, ELM",,,,,,,,,,,
516,236,L,R,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 235-238, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,18:60795871-60795871","hg19,18:g.60795871A>C",0.318,,,,
517,237,G,,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 235-238, ELM",,,,,,,,,,,
518,238,H,L,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 235-238, ELM",,cBioPortal,luad_cptac_2020,Lung Adenocarcinoma,"hg19,18:60795865-60795865","hg19,18:g.60795865T>A",0.117,,,,
519,239,K,,,,,,,,,,,s,,,,,,,,,,,,
